Gestational weight gain and modifiable risk factors of severe maternal morbidity in a hospital-based, retrospective cohort by Freese, Kyle
Title Page 
Gestational Weight Gain and Modifiable Risk Factors of Severe Maternal Morbidity in a 
Hospital-Based, Retrospective Cohort 
by 
Kyle Evan Freese 
BS in Physiology, University of Arizona, 2008 
MPH in Behavioral and Community Health Sciences, University of Pittsburgh, 2011 
Submitted to the Graduate Faculty of the 
Department of Epidemiology 
Graduate School of Public Health in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
University of Pittsburgh 
2019
 ii 
Committee Page 
UNIVERSITY OF PITTSBURGH 
 
GRADUATE SCHOOL OF PUBLIC HEALTH 
 
 
 
This dissertation was presented 
 
by 
 
 
Kyle Evan Freese 
 
 
It was defended on 
 
September 25, 2019 
 
and approved by 
 
 
Katherine P. Himes, MD, MS, Assistant Professor, Division of Maternal-Fetal Medicine, 
Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, 
University of Pittsburgh 
 
Maria M. Brooks, PhD, Professor, Departments of Epidemiology and Biostatistics, 
Graduate School of Public Health, University of Pittsburgh 
 
Kathleen M. McTigue, MD, MPH, MS, Associate Professor, Departments of Medicine 
and Epidemiology, School of Medicine and Graduate School of Public Health, University of 
Pittsburgh 
 
Dissertation Director: Lisa M. Bodnar, PhD, MPH, RD, Professor, Departments of 
Epidemiology and Obstetrics, Gynecology, & Reproductive Sciences, Graduate School of Public 
Health and School of Medicine, University of Pittsburgh 
 
 
 
 
 
 
 
 
 
 iii 
 
 
 
 
 
 
 
 
 
 
Copyright © by Kyle Evan Freese 
 
2019 
 
 
 
 
 iv 
Abstract 
Lisa M. Bodnar, PhD, MPH, RD 
 
 
Gestational Weight Gain and Modifiable Risk Factors of Severe Maternal Morbidity in a 
Hospital-Based, Retrospective Cohort 
 
Kyle Evan Freese, PhD 
 
University of Pittsburgh, 2019 
 
 
Abstract 
 
Severe maternal morbidity affects nearly 50,000 women every year and its incidence has 
risen over the past 3 decades. However, there remain several gaps in the epidemiologic literature. 
Our goal was to quantify the burden that modifiable risk factors place on severe maternal 
morbidity, with a focus on gestational weight gain because of its amenability to intervention 
during pregnancy. 
We used two, retrospective cohorts of delivery hospitalizations at Magee-Womens Hospital 
in Pittsburgh, PA to address three specific aims: 1) determine the association between total 
gestational weight gain and the risk of severe maternal morbidity, 2) determine the association 
between early gestational weight gain and the risk of severe maternal morbidity, and 3) calculate 
the population attributable fraction of known, modifiable risk factors of severe maternal morbidity. 
A total gestational weight gain z-score of +2 (31kg at 40 weeks gestation among normal 
weight women) was associated with 1.0 (0.46, 1.5)) excess cases of severe maternal morbidity per 
100 delivery hospitalizations compared with a z-score of 0 (16kg at 40 weeks among normal 
weight). Very low weight gain was also associated with an increased risk, though the magnitude of 
association was smaller. The relationship between early gestational weight gain and risk of severe 
maternal morbidity followed an inverted-U distribution, though the divergent findings with Specific 
Aim #1 were likely due to differences in sample characteristics. For Specific Aim #3, we found that 
 v 
optimizing eight, known risk factors concurrently could prevent 36% (626 cases) of the severe 
maternal morbidities in this sample. High gestational weight gain, high body mass index, advanced 
maternal age, preexisting hypertension, and lack of a college degree had population attributable 
fractions ranging from 4.5% to 13%.  
Our results suggest that optimizing individual-level risk factors, including gestational 
weight gain, would have modest impacts on reducing risk of severe maternal morbidity and that the 
burden of severe maternal morbidity is likely due to a constellation of components. This is 
significant for future public health efforts because, while additional research should confirm and 
extend our findings, the greatest change will likely come through addressing larger, population-
level factors and disparities. 
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1.0 Introduction 
1.1 Background 
Pregnancy-related maternal mortality occurs more frequently in the United States (U.S.) 
more than any other developed nation and its incidence has more than doubled over the past 
three decades.1 Because maternal mortality is often used as a metric for the health of the broader 
population, professional medical societies have called for more research to better understand its 
risk factors and causes.2 However, the cumulative incidence of pregnancy-related maternal 
mortality remains low,3,4 making it a challenging target for epidemiologic studies. Severe 
maternal morbidity shares etiologies and risk factors with pregnancy-related maternal mortality 
and occurs nearly 70-times more frequently. Therefore, severe maternal morbidity can be viewed 
as a reasonable proxy outcome for maternal mortality, allowing us to study and better understand 
the larger problem of increasing incidence of life-threatening pregnancy complications. 
Though several risk factors of severe maternal morbidity are cited in the available 
literature, many of those that are potentially modifiable are only amenable to intervention before 
conception. Given many women do not have access or do not seek healthcare before pregnancy5 
and half of pregnancies are unplanned,6 identifying risk factors that can be targeted during 
pregnancy, such as gestational weight gain, should be of high importance. Unfortunately, most 
administrative datasets that are powered to adequately study this rare outcome are limited in the 
depth and breadth of factors that can be studied.  
Furthermore, while there are known modifiable risk factors of severe maternal morbidity, 
the extent to which they contribute to the overall burden of severe maternal morbidity is not. For 
 2 
example, observational studies have reported on the association between prepregnancy BMI and 
severe maternal morbidity, but traditional measures of association (e.g. odds or risk ratios) cannot 
be readily translated to real-world implications of intervention. Methods such as calculating the 
population attributable fraction allow us to quantify the burden of severe maternal morbidity due 
to specific risk factors and estimate the number of cases that could be prevented by optimizing or 
reducing the prevalence of those risk factors. 
1.2 Specific Aims 
The overarching purpose of this dissertation is to address critical gaps in the literature 
regarding the contribution of individual modifiable risk factors of severe maternal morbidity, 
with a specific focus on gestational weight gain. Specifically, we will add to the current 
epidemiologic literature by 1) exploring the association between severe maternal morbidity and 
both, total and early gestational weight gain and 2) quantifying the proportion of severe maternal 
morbidity that is attributable to known, modifiable risk factors. We will accomplish the 
following aims using two separate datasets. For specific aim one, we will use a retrospective 
cohort of singleton pregnancies from Magee-Womens Hospital in Pittsburgh, Pennsylvania from 
2003-2012 (n=84,241). Specific aim two will be accomplished using a retrospective cohort of 
4,774 delivery hospitalizations from the same institution, augmented with data on serial weight 
measurements that were abstracted via medical chart review (2003-2011). For specific aim three, 
we will use a retrospective cohort of 86,260 of singleton and twin delivery hospitalizations from 
Magee (2003-2012). 
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Specific Aim 1. Determine the association between total gestational weight gain and severe 
maternal morbidity.  
Hypothesis: Higher gestational weight gain will be associated with increased risk of severe 
maternal morbidity. 
Specific Aim 2. Determine the association between early gestational weight gain and 
severe maternal morbidity.  
Hypothesis: Higher gestational weight gain at 16-19 weeks gestation will be associated 
with increased risk of severe maternal morbidity, but the magnitude of the association will be 
smaller compared with that of Specific Aim 2. 
Specific Aim 3. Determine the population attributable fraction of modifiable risk factors 
of severe maternal morbidity (maternal education, marital status, prepregnancy BMI, preexisting 
hypertension or diabetes, advanced maternal age at delivery, smoking during pregnancy, and 
gestational weight gain). 
Hypothesis: Chronic medical conditions and high prepregnancy BMI will account for the 
highest frequency of preventable cases of severe maternal morbidity.  
Overall impact: At the patient level, these results will provide clinicians with additional 
information on the association between risk factors and important, adverse health outcomes 
among women who are or thinking about becoming pregnant. For healthcare systems, 
quantifying the expected number of cases of severe maternal morbidity that could be prevented 
by optimizing individual risk factors may help identify priority surveillance areas. Filling gaps in 
the epidemiologic literature may also have broader, policy implications by demonstrating the 
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need to reduce the prevalence of known risk factors through improved education efforts and 
access to affordable healthcare. 
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2.0 Literature Review 
2.1 Introduction 
2.1.1 Pregnancy-related maternal health in the United States 
Historically, maternal health during pregnancy has fallen secondary to fetal health, 
following the traditional paradigm of “what is good for the child is good for the mother”.7 In 
1985, Rosenfield and Maine brought attention to the disparity in an important article in the 
Lancet, intending to motivate the public health community to better understand and address 
maternal mortality and improve maternal health”.8 But sadly, the rate of maternal mortality and 
morbidity continued to rise worldwide and over 30 years later, has more than doubled in the 
United States (U.S.), which by many measures, has the worst incidence of maternal death among 
all high-income countries. 
Maternal health is an important indicator of the overall health and healthcare system of a 
nation.9 So, together with rising obesity rates, chronic disease, and its related conditions, these 
trends signal a challenging future for healthcare in the U.S. In contrast, Scandinavian countries 
and the United Kingdom (U.K.) have both seen declines in maternal mortality so significant that 
in the U.K., “a [similar age] man is more likely to die while his partner is pregnant than she is”.10 
Though the problem surrounding declining pregnancy-related maternal health has been 
known to the scientific and medical communities for decades, the issue remained mostly 
unknown to the general U.S. public until recently. In 2017, ProPublica and National Public 
Radio (NPR) reported on Lauren Bloomstein, a neonatal nurse who died during childbirth in the 
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hospital where she worked. The first of an eight-article series, this report chronicled the events 
surrounding her death and the lapses in her care that contributed to the outcome. Since the series 
began, there has been a surge in public awareness and advocacy. And while increased attention is 
beneficial, much work is still needed to better understand why these events occur.  
Maternal mortality is the final endpoint in the continuum of adverse maternal outcomes 
during pregnancy, delivery, or postpartum, but its cumulative incidence remains low. However, 
severe maternal morbidity, which shared the risk factors and etiologies with maternal mortality 
and has short-and long-term ramifications of its own, occurs 70-times more frequently. Its 
incidence has increased nearly 200% from 1993 to 2014 (0.50% to 1.4% of delivery 
hospitalizations, respectively).1 By better understanding this outcome, the goal is to not only 
better understand potential modifiable risk factors of severe maternal morbidity, but along with 
additional research, gain insight into how better to identify, monitor, and treat women on the path 
to pregnancy-related mortality. 
2.2 Severe Maternal Morbidity 
2.2.1 Defining severe maternal morbidity 
Severe maternal morbidity is broadly defined as a life-threatening complication 
experienced during pregnancy, delivery, or postpartum.2,11 While professional medical societies 
have not endorsed a single definition, organ system failure, postpartum hemorrhage, and life-
saving medical intervention are commonly used indicators for severe maternal morbidity. 
Criteria in the available literature vary by the scope and underlying objective of the research as 
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well as the type of dataset used. For example, population-based, epidemiologic research using 
administrative data typically use broader criteria than chart-review efforts aimed at identifying 
preventable cases. For the former category, the Centers for Disease Control and Prevention 
(CDC) published a list of ICD-9 and ICD-10 codes, corresponding to 21 unique indicators of 
severe maternal morbidity that has been widely used.12 For the latter, where cases are screened 
and reviewed, the American College of Obstetricians and Gynecologists (ACOG) recommends 
screening criteria of blood transfusion of 4+ units or intensive care unit (ICU) admission, 
followed by detailed review of each screen-positive case.13 Hybrid definitions are also common 
because the available data vary between healthcare institutions and highlighting additional cases 
is warranted. 
Early definitions 
The definition of what constitutes a severe maternal morbidity has evolved since the mid-
1990s. Prior to this time, standard practice was to use hospital admissions as a proxy for near-miss 
morbidity.14 Once recognized that these criteria could not distinguish between life-threatening and 
non-life threatening events, some researchers moved to count ICU admissions instead.15,16 Though 
a much better indicator of serious events, using a single indicator is problematic because it cannot 
capture patients who deliver in facilities that do not have an ICU and may still not account for 
some critically ill women.14 So, from 2002-2004, Stacie Geller, et al. developed a conceptual 
framework and scoring system aimed at including additional factors that would 1) capture serious 
events better than current definitions and 2) further distinguish between serious events and true, 
life-threatening complications.14,17,18 Using a multi-stage review process whereby potential cases 
were identified, medical charts abstracted, narrative summaries compiled, and qualitative review 
conducted, the authors identified 5 factors– surgical intervention, extended intubation, >3 units of 
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blood transfusion, ICU admission, and organ system failure– as indicators of severe maternal 
morbidity. The two principal limitations of this work were the failure to review screen-negative 
cases and using qualitative review processes as their gold standard, the implications of which 
include failing to identify false negative cases and limited generalizability of results outside the 
study sample. Their approach, though not without shortcomings, helped foster new ways of 
thinking about how to study near miss events. Also, since these early efforts, myriad definitions 
have been proposed, but few have been the subject of internal and/ or external validation studies. 
Validation studies  
Available validation studies can be categorized into one of two, main groups based on the 
type of definition of severe maternal morbidity they aim to validate. The first group focuses on 
scoring systems (like the one developed by Geller, et al.) and the second, on multi-factor 
identification systems such as the CDC and ACOG criteria listed above.  
The Geller criteria have been the focus of two validation studies, one internal and the other 
external. An internal validation study by Geller, et al. found that compared with qualitative chart 
review, individual factors had sensitivities and specificities of 73%-96% and 82-99%, respectively. 
A single, external validation study by You, et al. reported lower sensitivities (42%-79%) and 
similar specificities (90%-99%) in a sample of 816 deliveries.19 However, neither group reviewed 
screen negative cases, so we cannot rely on these reported validation estimates. The authors should 
have reported the positive predictive value, as this is the only validation metric that can be reliably 
calculated using the review of screen-positive cases.  
Another notable validation study by Christine Roberts, et al., focused on developing a new 
set of criteria for identifying maternal morbidity using ICD-10 codes in a nested case-control 
control study of 400 possible cases and 800 controls in Australia.20 After applying sampling 
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weights, they determined the positive- and negative-predictive values as well as the sensitivity and 
specificity of each indicator compared with a gold standard of chart review. This is the only 
validation study where both, screen-positive and screen-negative cases were reviewed. 
Unfortunately, while some of the examined indicators align with those more commonly used in 
the U.S., many were unique to this sample. Indicators that align with common U.S. indicators 
include: eclampsia, disseminated intravascular coagulation, shock, cardiac failure, acute liver/ 
renal failure, sepsis, blood transfusion, hysterectomy, and ICU admission. Compared with the gold 
standard, these indicators had >83% positive predictive value, though their sensitivities ranged 
from 28% for hysterectomy to 100% for eclampsia. Negative predictive value and specificity was 
over 99% for all indicators.  These results illustrate two points: 1) there are several reasonable 
definitions for severe maternal morbidity (some more justifiable than others), but that any 
conclusion of the validity of each definition is highly dependent upon the clinical judgement of 
those developing the gold standard to which a definition is compared and 2) there are likely more 
indications of severe maternal morbidity than any one study has examined to date. For example, 
in this study, “trauma to abdominal organs” was associated with a 93% positive predictive value, 
65% sensitivity, and 99.8% specificity, but this indicator is not included in recent indications in 
U.S. studies. While many other indicators in this sample were less valid, there may be merit to the 
notion that a universal definition for severe maternal morbidity is not tenable or appropriate. 
In the U.S., the 2016, seminal article by Elliot Main et al. tested the validity of defining 
severe maternal morbidity using common individual and hybrid definitions against a gold standard 
of chart review. This study included over 67,000 delivery hospitalizations in 16 California 
hospitals. ICU admission and massive blood transfusions fared the best among individual 
indicators; hybrid definitions that included any of the CDC criteria, prolonged postpartum length 
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of stay, and ICU admission all performed reasonably well. Strengths of the study include the large 
sample size (>67,000 delivery hospitalizations across 16 hospitals) and their reviewing of several 
individual and hybrid definitions of severe maternal morbidity. The primary limitations, as with 
other validation studies, was that negative screens were not reviewed to obtain accurate 
sensitivities and specificities. Nevertheless, they reported positive predictive values, which were 
highest when blood transfusions were considered indicators of severe maternal morbidity only 
when at least 4 units of blood product was transfused (i.e. a transfusion of <4 units of blood product 
was not considered a near miss event). These positive predictive values ranged from 56% to 88%. 
Other definitions fared reasonably well, though with a rare outcome such as severe maternal 
morbidity, high positive predictive values are difficult to achieve, even with accurate definitions.  
Overall, several definitions of severe maternal morbidity are reasonable and appropriate 
depending on the specific aims of a research endeavor and the inherent limitations of datasets and 
available resources. As recommended, in the absence of consensus of a single definition, it is the 
responsibility of the researcher to create, adopt, or adapt an existing criteria.21 
2.2.2 Causes and indicators of severe maternal morbidity 
Severe maternal morbidity is a heterogeneous outcome with several distinct etiologies and 
phenotypes. Historically, there have been 3 approaches for categorizing the causes of near miss 
cases (based on disease-specific, management, and organ-system dysfunction criteria).22 However, 
the current paradigm focuses on vital organ dysfunction/ failure and related, severe complications 
as the principle drivers. 
Organ dysfunction or failure. Regulatory and research groups have recognized organ 
dysfunction or failure as an important, overarching cause of severe maternal morbidity.1,11 Though 
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definitions of severe maternal morbidity have evolved over the past two decades, cardiovascular, 
respiratory, cerebrovascular, renal, and hepatic dysfunction/ failure remain recognized 
contributors. Conditions noted with the highest frequency in the literature include: blood 
transfusion, organ system failure (e.g. cardiovascular or renal failure), as well as eclampsia. 
Appendix B includes the full list of conditions that the CDC include as indicators and causes of 
severe maternal morbidity. 
Severe complications. Separately, complications that occur during the peripartum period, 
such as hemorrhage, hypertensive disorders, obstructed labor, embolism, infection, sepsis, shock, 
and eclampsia may cause severe maternal morbidity.23-25  
Historically, infection was the leading cause of maternal morbidity and mortality. In the 19th 
century, sepsis was responsible for up to 50% of all maternal mortality.26 Recently, particularly in 
high-income settings, improved peripartum medical care and the introduction of new 
pharmacologic interventions has substantially reduced the burden; however, in some study 
populations, upwards of 1 in 4 cases are due to infection.25 Cited risk factors for infection and 
sepsis include: Cesarean delivery, multiple pregnancy, artificial reproduction techniques, and 
hysterectomy.25-27 
Consistently, postpartum hemorrhage accounts for the plurality of cases of severe maternal 
morbidity, but many reports lack consistent quality of data.23,24,28,29 For example, some datasets do 
not include the volume of blood products administered, but rather include a binary variable 
indicating whether a blood transfusion occurred. Some argue that transfusion of <4 units of red 
blood cells alone might not constitute severe maternal morbidity because the mother’s life was 
unlikely to be at risk. However, as discussed above, Main, et al. found that blood transfusion as an 
indicator was found to have high precision in identifying severe maternal morbidity when used as 
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part of a multi-factorial criteria system, though the positive predictive value increased if the 
definition was restricted to only including >4 units transfused.30 
2.2.3 Known risk factors of severe maternal morbidity 
2.2.3.1 Non-modifiable risk factors 
Several nonmodifiable risk factors of severe maternal morbidity have been identified. First, 
those with placental anomalies are as much as 36-91 times greater for those with placenta accreta 
(placenta attaching too deep in the uterine wall) and 1-3 times greater for those with placental 
abruption compared with women without these characteristics.31 Second, shorter gestation has 
been associated with increased risk of severe maternal morbidity. In a cohort of over 115,000 
women, those delivering earlier than 37 weeks gestation exhibited higher risk than those who 
delivered at 39+ weeks’ gestation (12.3/1,000 vs. 1.4/1,000, respectively). Women who delivered 
between 23-27 weeks were at the greatest risk (OR=9.1 [5.5, 15.0])31 with other research groups 
finding similar effects.32,33 Third, incidence of gestational diabetes is nearly 3-times higher in 
women with gestational diabetes compared with women free of diabetes (6.9/ 1,000 vs. 2.5/1,000, 
respectively).31 Gestational diabetes might be viewed as a modifiable risk factor due to weight 
maintenance, etc., but within the context of a stand-alone risk factor, we choose to include it in 
this section. Fourth, racial and ethnic minorities exhibit some of the most elevated rates of severe 
maternal morbidity. Black women are at the highest risk compared with non-Hispanic Whites 
(28.4/ 1,000 deliveries vs. 11.4/ 1,000 deliveries, respectively).32,34-39 Hispanic women have also 
been shown to be at increased risk (14.5/ 1,000) and Asian/ Pacific Islanders/ American Indians/ 
Alaskan Natives all exhibit approximately 1-1.5 times the risk compared with White women.39 
Fifth, women who have undergone a previous Cesarean delivery are approximately 2 times as 
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likely to experience severe maternal morbidity after adjusting for education, payer source, age, 
race, smoking status, parity, preexisting conditions, multiple births, and BMI (OR=2.0 [1.4, 3.0]).36 
Sixth, multiparous and nulliparous women are at increased risk of severe maternal morbidity 
compared with primiparous women, though the magnitude of effect is relatively small (8% higher 
among cases).36,40 Lastly, compared with singleton births, delivering multiples has been associated 
with 2-4 times the risk of severe maternal morbidity, which is consistent across studies.32,36,41 
While there are many non-modifiable risk factors for the causes of severe maternal morbidity, 
there are others that might be effective targets of clinical intervention. 
2.2.3.2 Modifiable risk factors 
Preexisting, chronic disease increases the risk of severe maternal morbidity. In particular, 
hypertension, diabetes, asthma, cardiac disease, sickle cell disease, and cerebrovascular disease 
are all positively associated. In a large case-control study (9,500 cases and 41,000 random 
controls), women with a preexisting condition were at 2 times the risk compared with those without 
(OR=2.1 [1.9, 2.3]).36 Similar findings have been reported in other populations, including in chart 
review and cohort studies.29,39  
Cesarean delivery is positively associated with severe maternal morbidity, with 3 to 8-fold 
increased magnitude of risk. 33,42-44 While there is consensus regarding the association between 
Cesarean delivery and severe maternal morbidity, there may be merit in the notion of 
distinguishing between primary or repeat procedures (since 30-40% of Cesarean deliveries in the 
U.S. are repeat procedures) and timing of delivery, though the epidemiologic literature in this area 
is sparse.42,45,46  
Obesity is a commonly studied risk factor for severe maternal morbidity,29,33,42 yet there is 
some disagreement in the literature regarding the direction and magnitude of the association. For 
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example, in a large cohort study, obesity was found to be associated with mild, increased risk of 
severe maternal morbidity (OR: 1.2, [1.1, 1.3]).36 Similar effects have been reported throughout 
the literature with the exception of a recent population-based retrospective cohort study, which 
found no association with BMI (measured as a continuous variable).47 These disparate results 
might be a function of methodologic differences regarding study design, confounder selection, as 
well as exposure and outcome definition. A crucial component of our proposal is using theory-
based causal graphs to select appropriate confounders.48  
Maternal age, while not modifiable at the individual level, has been shown to be associated 
with increased risk of severe maternal morbidity.36 The mean age of mothers in the U.S. has 
increased over the past 15 years, with women’s age at their first birth having the largest increase 
(24.9 years to 26.3 years).49 In a cohort of more than 3 million women, the risk of severe maternal 
morbidity increased with age,39 a finding supported by a separate study that found mothers ≥35 
years of age are at a modest increased risk compared with women <35 years of age (241.9/1,000 
vs. 178.0/1,000).36  
Smoking during pregnancy has a mild effect on severe maternal morbidity risk. It has been 
associated with 1-1.5 times the risk, however few studies have examined the association.31,36 In 
the two studies we are aware of on this topic, the effect estimates indicated only mild increased 
risk above non-smokers. Furthermore, there was no distinction regarding smoking amount, which 
has been shown to impact pregnancy outcomes.50 
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2.3 Total Gestational Weight Gain 
Inadequate or excessive gestational weight gain is associated with several adverse 
maternal, fetal, and child health outcomes.51-55 However, to our knowledge, only one study has 
formally examined the association between gestational weight gain and severe maternal morbidity.  
In 2019, Marissa Platner, et al. reported that weight gain above the 2009 IOM 
recommendations was associated with increased risk of severe maternal morbidity. In a 
retrospective sample of over 500,000 term, singleton deliveries, this group defined their outcome 
as the presence of any 1 of the 21 CDC indicators (excluding those with implausibly short length 
of stay, which was not specified), maternal death, or maternal transfer to another facility. 
Gestational weight gain was defined as within, below, 1-19 lbs above, or 20+ lbs above the IOM 
recommendations by prepregnancy BMI category. Adjusted logistic regression was performed and 
odds ratios calculated. The authors found that weight gain 1-19lbs above the IOM guidelines was 
associated with an 8% (2%-13%) increased odds of severe maternal morbidity compared with 
those who gained within the guidelines. Even higher weight gain (20+ lbs above the guidelines) 
was associated with 20% (12%-31%) increased odds, compared with the same referent. Overall, 
this was a well-designed and executed study; however, the principal limitation was this groups’ 
exclusion of preterm deliveries, of which upwards of 40% of all severe maternal morbidity cases 
are a part.32 Additional research is needed to fill this gap in the literature. 
Though only Platner, et al. has reported on the direct association between gestational 
weight gain and severe maternal morbidity, previous efforts have shown that many of the adverse 
health outcomes for which suboptimal gestational weight gain is a risk factor are themselves risk 
factors for or causes of severe maternal morbidity, discussed below. 
 16 
2.3.1 Vital organ dysfunction 
Hypertensive disorders. It is well-established that preeclampsia and other hypertensive 
disorders are risk factors or causes of severe maternal morbidity.56 Hypertensive disorders 
themselves are often the result of arterial stiffness and endothelial dysfunction, which may lead to 
renal and liver impairment, pulmonary edema, as well as other adverse, vascular anomalies. The 
epidemiologic literature on gestational weight gain and pregnancy-related hypertensive disorders 
is varied in quality. However, in a cohort of nearly 12,000 women, for every 200 grams per week 
gains up to 18 weeks gestation, there was approximately a 1.3 times increased risk of gestational 
hypertension and preeclampsia.57 
Several plausible physiologic mechanisms may explain how excessive gestational weight 
gain may increase the risk of severe maternal morbidity by way of hypertensive disorders during 
pregnancy. First, women who gain excessive weight during pregnancy may express similar 
physiologic characteristics as overweight or obese individuals. Excess weight may lead to 
impairments in vasodilation properties, increased sympathetic activity, insulin resistance, and over 
activation of the renin-angiotensin system, and as a result, hypertension.58 It has also been 
proposed that obesity leads to high activation of the nuclear factor kB pathway and increased 
superoxide (O2
-) generation in the vascular wall may contribute to decreased bioavailability of 
nitric oxide, which plays a major role in endothelial behavior.58 Dysfunction in these systems may 
lead to loss of vascular homeostasis. Second, increased visceral adiposity (such as that caused by 
excessive weight gain) may to physical compression of the kidneys, activation of the renin-
angiotensin-aldosterone system, and increased sympathetic nervous system activity, which act as 
mediators of abnormal kidney function and hypertension.59 To summarize, 1) increased adiposity 
may lead to endothelial dysfunction directly, which may cause one to develop hypertension, or 2) 
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physical compression of the kidneys due to excessive adipose tissue in the same compartment 
initiates a cascading reaction that may lead to hypertension. 
Acute renal failure/ dysfunction. No known epidemiologic evidence exists on the 
association between gestational weight gain and renal dysfunction in pregnancy; however, as 
above, there are several pathways that may explain the relationship. In general, acute kidney injury 
is usually caused by ischemia, hypoxia, inflammation, and nephrotoxicity.60 Adipose tissue and 
adipose-derived stem cells, which are associated with low-grade inflammation and hypoxia, exert 
influence on the microenvironment of surrounding tissues via paracrine and endocrine action.61,62 
Therefore, with the unique pattern of fat accretion during pregnancy (depositing preferentially over 
the hips, back, and upper thighs up to ~30 weeks’ gestation),63 it is plausible that physical 
compression of the kidneys can lead to their dysfunction and more indirectly, endothelial 
dysfunction caused by increased adiposity may lead to renal impairment.58,59 
Acute liver failure. Pregravid central obesity increases the risk of nonalcoholic fatty liver 
disease.64 The liver plays a key metabolic role in lipid metabolism, which proves exceedingly 
important with high calorie and fat consumption.65 Through increased activation of transcription 
factors and a cascade involving fatty acid transport, translocase, and binding proteins, lipid 
droplets can begin to form within the hepatocytes. This accumulation is the hallmark of a variety 
of liver disorders including acute fatty liver in pregnancy. Though difficult to establish without 
rigorous dietary monitoring during pregnancy, it is possible that excessive weight gain during 
pregnancy, particularly if due to an imbalanced diet that is high in fat, places a woman at increased 
risk for fatty liver development, liver dysfunction and potentially, severe maternal morbidity. 
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Gestational diabetes. Pregnancy is a period characterized by increased insulin sensitivity. 
A recent systematic review found that, among 8 studies and 13,748 total participants, excessive 
gestational weight gain before glucose screening was positively associated with the odds of 
gestational diabetes compared with those without excessive gestational weight gain (OR=1.4 [1.2, 
1.6]).66 Diabetes, while not a primary cause of severe maternal morbidity, may increase the risk of 
experiencing a near miss.42 Furthermore, if left untreated, these elevated blood glucose levels may 
damage vital organ systems such as the cardiovascular and renal systems, the dysfunction of which 
are known causes of severe maternal morbidity.67 
Respiratory anomalies. Elevated pregravid BMI and excess weight gain during pregnancy 
may act amplify already diminished respiratory function, a characteristic common in overweight 
and obese individuals outside of pregnancy. 68,69 Some evidence suggests that prepregnancy 
obesity and excessive gestational weight gain are associated with increased risk of maternal 
respiratory complications.70 
2.3.2 Severe complications 
Hemorrhage. Evidence suggests an association between excessive gestational weight gain 
and postpartum hemorrhage.71,72 Possible mechanistic links for this association include the 
susceptibility of prolonged labor with increased risk of uterine atony, increased pelvic soft tissue 
narrowing the birth canal, and hemostatic changes due to increased adiposity. Epidemiologic 
evidence suggests that in some populations, postpartum hemorrhage is responsible of up to 50% 
of all cases of severe maternal morbidity, but the lack of standardization in research settings, 
clinical disagreement regarding what volume of blood loss constitutes severe maternal morbidity, 
and the availability of robust data have made the study of this risk factor difficult. 
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Sepsis/ Shock. Finally, while gestational weight gain is not likely to increase the risk of 
infection or sepsis directly, excessive weight gain during pregnancy has been linked to higher rates 
of Cesarean delivery, which is a risk factor for both, sepsis and severe maternal morbidity. 
2.4 Early Gestational Weight Gain 
Gestational weight gain early in pregnancy is associated with maternal health 
outcomes. Weight gain early in pregnancy is a risk factor for many other pregnancy outcomes for 
both, mother and child, including delivering small or large for gestational age infants, maternal 
development of comorbidities such as gestational diabetes, asthma, or hypertensive disorders of 
pregnancy.73,74 However, to this point, no one has endeavored to examine this exposure within the 
context of severe maternal morbidity. Our concurrent work (Specific Aim 2) supports an 
association between elevated, total gestational weight gain and severe maternal morbidity, but 
there is evidence that early weight gain might also be associated with risk of several, known risk 
factors or causes of severe maternal morbidity. 
The available literature suggest that excess weight gain early in pregnancy has a negative 
effect on pregnancy outcomes and for certain outcomes, may be more critical than total gestational 
weight gain. First, it has been shown excessive weight gain in the first trimester is associated with 
an ~20% increased odds 95% confidence interval: 0.2%, 51%) of gestational diabetes compared 
with those who do not experience excessive weight gain,75 a trend that was supported by a separate 
chart review study of 413 women that found an association between first trimester weight gain and 
risk of hyperglycemia.76 Furthermore, these associations did not persist with gestational weight 
gain in the second trimester or beyond. Second, compared with women who remain within the 
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recommended weight gain during the first half of pregnancy, women who gain more weight during 
the same period are at increased risk of developing hypertensive disorders during pregnancy 
(125/1,000 versus 86/1,000, respectively),57,77 a precursor for several causes of severe maternal 
morbidity. Third, excessive gestational weight gain in the first trimester might be associated with 
increased asthma exacerbation during pregnancy.78 Incident asthma places one at higher risk of 
several causes of severe maternal morbidity, including placental anomalies, hemorrhage, 
pulmonary embolism, and intensive care unit admission,79 all of which are causes of severe 
maternal morbidity. A common theme for the 3 examples above is that the magnitude of 
association with early weight gain is comparable or stronger than available evidence supporting 
their association with total weight gain. 
Exploring gestational weight gain early in pregnancy because we can isolate weight gain 
before the development of any of the conditions above that might alter woman’s weight gain 
trajectory (through clinical intervention or the natural course of disease). For example, at Magee-
Womens Hospital, women are screened for gestational diabetes from 24-28 weeks gestation; any 
subsequent clinical intervention to treat the condition might lead to lower, total weight loss than if 
no intervention had been given. Also, women who develop hypertensive disorders during 
pregnancy are more likely to experience edema compared with women who remain normotensive, 
which might result in greater, total weight gain; however, weight gain in the first half of pregnancy 
is less likely a function of clinical edema caused by hypertensive disorders57 There is sufficient 
evidence, both epidemiological and physiological, to support an association between early 
gestational weight gain and severe maternal morbidity, but no one has formally examined the 
relationship. This is an important gap in the literature that this project will fill. 
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2.5 Population Attributable Fraction in Pregnancy Research 
An overarching gap in the epidemiologic literature on severe maternal morbidity is that, 
while many risk factors have been identified, none have endeavored to quantify the burden that 
these risk factors contribute to severe maternal morbidity. As demonstrated above, epidemiologic 
studies thus far have reported associations for various exposures and the risk of severe maternal 
morbidity to various degrees (e.g. preexisting medical conditions, elevated body mass index, and 
so on), but we do not know how those associations translate could translate to real-world 
reductions in severe maternal morbidity.  
Calculating the population attributable fraction allows us to calculate the percent of 
severe maternal morbidity attributable to the risk factor of interest. Said another way, this 
method provides a way to calculate the percent of cases of a given outcome that could be 
prevented if the prevalence of a known risk factor was modified. 80 Given the output generated 
using this method, it has practical implications for informing interventions. 
Population attributable fractions have been used across research fields, including those 
studying adverse pregnancy outcomes. One of the largest studies to incorporate this methodology 
was a systematic review and meta-analysis by Flenady, et al., which was published in the Lancet 
in 2011.81 Here, the authors calculated the burden of risk factors of stillbirth in high income 
countries and found population attributable fractions ranging from 4-23%, depending on the risk 
factor. Similar methods have been used in other high-profile research and is recognized as a 
valuable tool in providing practical information for public health intervention efforts.82,83 
Severe maternal morbidity as an outcome is a well-suited candidate for the use of this 
method. First, one of the assumptions of calculating population attributable fractions is that the 
risk factors that are being calculated are modifiable, of which severe maternal morbidity has 
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several. Second, for population attributable fractions to be reliable, the analysis must be performed 
in a well-defined population. Since much severe maternal morbidity research is done at individual 
institutions, there is less heterogeneity in sample demographics. Third, severe maternal morbidity, 
like nearly all pregnancy-related adverse outcomes, can be measured in a short time frame 
(compared with say, development of cardiovascular disease). Finally, given severe maternal 
morbidity and mortality are the worst endpoints of pregnancy among mothers, there is heightened 
interest in developing interventions to decrease its incidence. Taken together, new research in this 
field should use practical approaches like population attributable fraction to present results that are 
geared towards translation to clinical practice. 
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3.1 Abstract 
Objective 
High pregnancy weight gain has been associated with severe maternal morbidity among 
term deliveries. We tested this association and extended it to preterm deliveries, which make up 
half of all cases. 
Methods 
We used a retrospective cohort of 84,241 delivery hospitalizations from Magee-Womens 
Hospital, Pittsburgh, PA (2003‒2012). Total gestational weight gain was assessed using 
gestational age- and body mass index (BMI)-specific z-scores. We defined severe maternal 
morbidity as the presence of any 1 of the 21 Centers for Disease Control and Prevention diagnosis 
or procedure codes, admission to the intensive care unit, or extended postpartum length of stay. 
We used multivariable logistic regression stratified by term/preterm birth to determine the 
association between total gestational weight gain and risk of severe maternal morbidity after 
adjusting for confounders.  
Results 
Severe maternal morbidity occurred in 4.7% and 1.2% of delivery hospitalizations among 
preterm and term deliveries, respectively (1.9% overall). Among term deliveries, the risk of severe 
maternal morbidity was flat from a weight gain z-score of -2 SD to +0.5 SD, after which it 
increased. A z-score of +2 and +3 (equivalent to 31kg and 41kg at 40 weeks gestation for a normal 
weight woman) were associated with 0.53 (95% confidence interval 0.09, 0.96) and 0.86 (0.09, 
1.6) excess cases of severe maternal morbidity per 100 delivery hospitalizations compared with a 
z-score of 0 (16kg at 40 weeks). Low weight gain was not associated with risk of severe maternal 
morbidity in this group. Among preterm deliveries, the adjusted risk of severe maternal morbidity 
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decreased from a z-score of -3 (6.6/100), reaching its nadir at a z-score of approximately +0.5 SD 
(5.71/00), after which it increased until a z-score of +3 (9.1/100). In this group, low weight gain 
was mildly associated with increased risk of severe maternal morbidity, with a z-score of -3SD 
associated with 0.44(-1.4, 2.2) excess cases per 100 delivery hospitalizations. High weight gain 
was associated with the highest number of excess cases among preterm deliveries, with a z-score 
of +0.3 SD associated with 3.0 (-0.54, 6.6) excess cases. 
Conclusions 
Excessive gestational weight gain is associated with increased risk of severe maternal 
morbidity during delivery hospitalizations in both, term and preterm deliveries and low weight 
gain is associated with increased risk among preterm deliveries. Interventions aimed at avoiding 
very high weight gain during pregnancy might reduce the risk of severe maternal morbidity. 
3.2 Introduction 
Severe maternal morbidity affects over 50,000 women every year in the U.S, more than 
double that than women in the U.K.84 Its incidence in the US has doubled since 1993,1,22 paralleling 
the increase in pregnancy-related maternal mortality.1,13,85 Examples of severe maternal morbidity 
include eclampsia, myocardial infarction, pulmonary embolism, renal failure requiring dialysis, or 
hemorrhage requiring an unplanned hysterectomy.1 Severe maternal morbidity often leads to 
extended hospital stays, long-term rehabilitation, prolonged morbidity, and decreased quality of 
life.23,86-88 To reduce risk, professional medical associations stress improvements in the quality of 
healthcare and identification of high risk women during pregnancy and delivery.21 However, major 
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gaps remain in our understanding of modifiable risk factors for severe maternal morbidity that 
could be targets for prevention.  
The obesity epidemic is thought to be a major contributor to the rise in severe maternal 
morbidity.85,89 Modifying weight before conception, however, is challenging because most women 
do not seek preconception care5 and half of pregnancies are unplanned.6 Alternatively, weight gain 
during pregnancy can be effectively managed using antenatal lifestyle interventions .90,91 A recent 
study examined the relation between gestational weight gain and severe maternal morbidity among 
term deliveries in New York City.92 The authors reported that pregnancy weight gain in excess of 
the 2009 Institute of Medicine weight gain recommendations had a positive association with severe 
maternal morbidity. Nevertheless, around 40% of severe maternal morbidity cases deliver 
preterm31,32 and whether these findings are generalizable to all cases is not known.  
We sought to determine the association between total gestational weight gain and the risk 
of severe maternal morbidity separately among preterm and term deliveries. 
3.3 Methods 
Data source 
We used a retrospective cohort of delivery hospitalizations at Magee-Womens Hospital of 
the University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania. Data came from the 
Magee Obstetrics, Medical, and Infant (MOMI) database, an electronic data repository, which 
populates information from admitting services, medical records coding (procedure & diagnosis 
codes), medical record abstraction, the birth record, ultrasound and other ancillary systems. 
Administrators routinely examine the database to ensure accuracy and verify the information with 
 27 
medical records. An inter-rater reliability study showed excellent agreement for self-reported 
prepregnancy weight, self-reported height, and gestational age at delivery.93 This analysis was 
approved by the University of Pittsburgh Institutional Review Board. 
There were 88,713 delivery hospitalizations in the MOMI database from 1-January-2003 
to 31-May-2012, when all key variables for this analysis were routinely available. We excluded 4 
records that were missing data on infant sex, parity, and dates of admission and discharge as well 
as 242 records with a gestational age at delivery <20 or >42 weeks. We excluded 4,226 multiple 
gestations because their gestational weight gain and mean gestational age at delivery differ from 
singleton pregnancies.94,95 The final analytic sample was 84,241.  
Exposure definition 
Prepregnancy weight was self-reported at the first prenatal visit. Body mass index (BMI) 
was calculated using prepregnancy weight (kg) divided by prepregnancy height (m2) and 
categorized as underweight (<18.5 kg/m2), normal weight (18.5-24.9 kg/m2), overweight (25.0-
29.9 kg/m2), obese (≥30.0 kg/m2).96 Weight at delivery was based on last measured antenatal 
weight or a self-reported weight at delivery.  Total gestational weight gain (kg) was calculated by 
subtracting prepregnancy weight from delivery weight. To remove the correlation between 
gestational weight gain and length of pregnancy,97-99  we converted total weight gain to gestational 
age-standardized z-scores based on prepregnancy BMI category-specific charts. These charts were 
created using serial weight gain measurements from a sample of women with healthy, term 
pregnancies at Magee-Womens Hospital.97,98  
Outcome definition 
We defined severe maternal morbidity as having any of the following criteria: the presence 
of any one of the twenty-one Centers for Disease Control and Prevention International 
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Classification of Diseases (9th revision) diagnosis or procedure codes used for the identification of 
severe maternal morbidity (See appendix A for specific ICD-9 codes),12,23 maternal admission to 
the intensive care unit (ICU), or extended postpartum length of stay (>3 standard deviations 
beyond the mean length of stay according to mode of delivery).30 We chose this definition because 
these criteria are commonly used in studies relying on administrative data.30 We determined the 
sensitivity of our results to removing each of the 3 criterion or eclampsia, severe anesthesia 
complications, and puerperal cerebrovascular disorders  if they were they only indicator of severe 
maternal morbidity. Others have shown that misclassification may be common in these ICD 
codes.100  
Covariates 
Gestational age was determined using the best obstetric estimate based on a comparison of 
menstrual dating and ultrasound dating101 ascertained from the medical record. Preterm birth was 
defined as delivery of a live-born infant at <37 weeks’ gestation. Self-reported data were available 
on maternal race/ethnicity (non-Hispanic White, non-Hispanic Black, and Other), education (less 
than high school, high school graduate, some college, and college graduate), smoking during 
pregnancy (yes/no), marital status (married, unmarried), and maternal age (5-knot restricted cubic 
spline). Insurance type (private/ other) and parity (none or ≥1) came from newborn records. 
Preexisting hypertension (yes/no) and preexisting diabetes (yes/no) were based on ICD-9 codes.  
Statistical analysis 
In our final analytic sample, records were missing data on prepregnancy weight or height 
(24%), delivery weight (8.6%), length of hospital stay (3.6%), maternal education (0.5%), or 
race/ethnicity (0.05%). We addressed the missing data using multiple imputation by chained 
equations (MICE), which allows for the specification of independent distributions for each 
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imputed variable.102,103 We jointly imputed mother’s height, prepregnancy weight, delivery 
weight, length of stay, education, and race/ethnicity using data on preexisting conditions, year, 
route of delivery, maternal age, smoking, parity, gestational diabetes, insurance, marital status, 
fetal death, gestational age at delivery, maternal ID, and census tract of residence). All continuous 
variables were log-transformed before the imputation. We created 25 imputed datasets to stabilize 
our variance estimates.104 Counts of subjects in each BMI group were averaged over the imputed 
datasets. We also performed a sensitivity analysis using the sample with complete data (n=57,922). 
We estimated the association between gestational weight gain and severe maternal 
morbidity using multivariable logistic regression. Models use generalized estimating equations 
and an exchangeable correlation structure to account for 11,224 repeated pregnancies in the cohort. 
A priori, in addition to performing nonstratified analyses, we stratified models by term and preterm 
birth. Denominators were based on all delivery hospitalizations. To accommodate flexible, 
nonlinear relations, we specified total gestational weight gain z-score as a restricted cubic spline 
with 3 knots determined by Akaike information criterion and placed at 10%, 50%, and 90% on the 
distribution.105 We used theory-based causal graphs106 to identify potential confounders, which 
were set to the population means and included in the final model. After model estimation, we used 
the ‘margins’ command in STATA to calculate adjusted predicted probabilities, risk differences 
and corresponding 95% confidence intervals for selected z-score values ranging from -3 SD to +3 
SD. We multiplied the adjusted risk differences and 95% confidence intervals by 100 to estimate 
the number of excess cases of severe maternal morbidity per 100 delivery hospitalizations. 
Associations between pregnancy weight gain and other health outcomes tend to vary by 
prepregnancy BMI,107 so we reran models separately for normal weight, overweight, and obese 
women (counts of cases among underweight women were prohibitively small). Further, we reran 
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models using the sample with complete data as well as with modifications to the definition of the 
outcome. 
3.4 Results 
Women tended to be non-Hispanic White, multiparous, married, college-educated, normal 
weight, and had private health insurance (Table 1). The mean (standard deviation) age of mothers 
was 29 (6.1) years and the mean gestational age at delivery was 38 (2.5) weeks in the overall 
population. The incidence of preterm birth was 11%. Compared with women who delivered at 
term, those who delivered preterm were more likely to be unmarried, less educated, and smokers, 
and have preexisting hypertension or diabetes and use non-private health insurance.  
In the overall sample, the mean gestational weight gain was 15(7.0) kg (z-score (SD) -
0.10(1.1), and 16 (5.7), 16 (5.9), 15 (7.2), and 12 (8.8) kg among underweight, normal weight, 
overweight, and obese women, respectively. Total pregnancy weight gain was higher in term (15 
(6.9) kg) compared with preterm deliveries (12 (7.3) kg), but weight gain z-scores did not differ (-
0.09(1.0) and -0.12(1.3), respectively). Women who were younger, non-Hispanic White, 
unmarried, had preexisting hypertension or diabetes, had completed some college, did not smoke 
during pregnancy, or were nulliparous tended to have higher gestational weight gain z-scores 
(Table 2). There were negligible differences in weight gain by insurance status. There were similar 
patterns in term and preterm deliveries with one exception: women who delivered preterm and 
were married tended to have higher weight gain.  
Overall, severe maternal morbidity occurred in 1.9 per 1000 delivery hospitalizations 
(n=1,598) and was over five times as common in preterm (6.4%) versus term (1.3%) deliveries 
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(Table 3). Among both term and preterm deliveries, women who were obese, non-Hispanic Black, 
unmarried, lacking private health insurance and started pregnancy with hypertension or diabetes 
were more likely than their counterparts to have severe maternal morbidity (Table 3). Overall and 
in term deliveries, women who were younger and less educated were more likely to have severe 
maternal morbidity, but preterm deliveries among older women were more likely to face a severe 
event. There were no differences in the incidence of the outcome by parity in preterm deliveries 
or smoking in term deliveries. However, term nulliparas had a higher incidence than term 
multiparas, and non-smokers had a higher incidence than smokers in preterm births.  Compared 
with term cases of severe maternal morbidity, cases occurring preterm were more likely to be 
admitted to the ICU, have a long postpartum stay, or have acute renal failure, adult respiratory 
distress syndrome, eclampsia, pulmonary edema, shock, sickle cell anemia with crisis, 
hysterectomy, or require ventilation, and less likely to have heart failure, puerperal cerebrovascular 
disorders, or severe anesthesia complications (Appendix I).  
Overall, the unadjusted incidence of severe maternal morbidity followed a J-shaped 
distribution (Table 4), with a weight gain z-score of ≥+2 SD associated with the highest risk 
(3.9/100 delivery hospitalizations), a z-score from -1 to <0 the lowest (1.7/100), and a z-score<-2 
similar to z-scores +1 to <+2 (2.5 and 2.4/100, respectively). Term and preterm births followed a 
similar pattern (Tables 5 and 6), but the highest unadjusted risk among term deliveries with z-
scores≥+2 SD was 2.7/100 and among preterm deliveries with the same z-scores, 9.3/100. 
After adjusting for maternal age, prepregnancy BMI, race/ ethnicity, parity, education, 
preexisting hypertension/ diabetes, method of payment, marital status, and smoking during 
pregnancy, there was a non-linear association between gestational weight gain z-score and risk of 
severe maternal morbidity in our overall analysis as well as among term and preterm deliveries 
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(Figures 1 and 2). Risk decreased gradually from a z-score of -3 to approximately +0.5, after which 
it increased. Compared with a weight gain z-score of 0 (16kg among normal weight woman at 40 
weeks), pregnancy weight gain z-scores of +1 and +2 (equivalent to 23 kg and 31 kg at 40 weeks)) 
were associated with 0.38(0.20, 0.56) and 1.0(0.46, 1.5) excess cases of severe maternal morbidity 
per 100 delivery hospitalizations, respectively (Table 7). Furthermore, in the extremes of weight 
gain, compared with the same referent, a z-score of +3 (41kg at 40 weeks among normal weight 
women) was associated with 1.6(0.68, 2.6) excess cases. There was more variability in the point 
estimates among low weight gain groups when we stratified analyses by prepregnancy BMI 
category, but the relationships were not meaningfully different to warrant alternative conclusions; 
point estimates were not meaningfully different in high weight gain groups, though compatibility 
intervals were wider in stratified analyses, as expected (Appendix E). In analyses limited to 
complete cases or after modifying the definition of the outcome, there was no meaningful 
differences in associations (data available upon request). 
3.5 Discussion 
Our data suggest that gestational weight gain outside normal ranges is associated with 
increased risk of severe maternal morbidity. In terms of absolute risk, preterm deliveries were at 
higher risk of severe maternal morbidity across all z-scores had roughly a 4-fold higher risk of 
severe maternal morbidity from weight gain z-scores from -3 to +3 SD. Importantly, our estimates 
were of the strongest magnitude in the highest strata of weight gain (i.e. >50 lbs for normal weight 
women at 40 weeks gestation). This is relevant because we found only 13% of women gained 
within these ranges (13% among term and 16% among preterm deliveries. Our results suggest that 
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high gestational weight gain is a moderately potent risk factor for severe maternal morbidity. 
Taken together, our findings help add support to the importance of avoiding very high weight gain 
during pregnancy.54 
This is an important contribution to the literature because we confirm and extend the 
findings of previous reports. Others have shown that high gestational weight gain is associated 
with severe maternal morbidity92 and other adverse perinatal outcomes,54,108 but we are the first to 
examine the former among both, preterm and term deliveries. This is a valuable addition because 
nearly half of all severe maternal morbidities occur in deliveries before 37 weeks gestation.32 In 
the only other known, published study of the association between gestational weight gain and 
severe maternal morbidity, Platner, et al. reported that among term deliveries, the odds of severe 
maternal morbidity was elevated among those who gained 1-19 pounds above the 2009 Institute 
of Medicine recommendations (OR (95% CI): 1.08 (1.02, 1.13)) and even higher among those who 
gained 20 or more pounds above the recommendations (1.21 (1.12, 1.31)) compared with those 
who gained within the recommendations.92 Our findings support their conclusions among term 
deliveries, including the threshold of gestational weight gain at which a substantial increase in risk 
is observed (approximately >20 pounds above the IOM recommendations for normal weight 
women).94 Among preterm deliveries, however, we found that the risk of severe maternal 
morbidity was over 3-times higher than term deliveries across all z-scores ≥0.5 SD (~19kg among 
normal weight women at 40 weeks gestation). Furthermore, we found that very low weight gain 
was associated with slightly increased risk of severe maternal morbidity, but only among preterm 
deliveries. Our finding that low weight gain was not associated with increased risk among term 
deliveries follows Platner, et al, who found no effect among those who gained less than the IOM 
recommendations. Though we found no evidence of effect measure modification by gestational 
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age at delivery of the association between gestational weight gain and severe maternal morbidity, 
knowing that women who deliver preterm are at increased risk of severe events should give 
clinicians pause when determining risk status. This would be of added importance for multiparous 
mothers with a history of preterm birth. Though we do not recommend departing from the current 
guidelines,94 we urge clinicians to educate their patients about the potential risks of gaining too 
little or too much weight during pregnancy. 
Our findings must be considered within the context of the study limitations. The first broad 
group of limitations is commonly encountered when studying severe maternal morbidity. 
Professional obstetrical societies have not endorsed a single comprehensive definition of severe 
maternal morbidity and we use criteria used widely in studies employing administrative 
databases.12,32,34,36,39 However, compared with current gold standard criteria, it is likely that we 
overestimated the incidence of severe maternal morbidity (more specifically, some cases may not 
have been sentinel events). Conversely, there are two ways in which we could have underestimated 
the true incidence; 1) there is potential for false negatives when identifying morbidity from 
administrative databases and 2) our outcome window was limited to delivery hospitalizations.30  
Though it is common to identify severe maternal morbidity during delivery hospitalization, it is 
well known that severe events can occur before or after this timeframe.23 Without data from a 
validation study on the positive predictive value of our definition, stratified by gestational weight 
gain categories, it is difficult to know if this introduced bias into our associations. Finally, because 
severe maternal morbidity is a heterogeneous outcome with multiple etiologies and phenotypes, it 
is likely that excessive gestational weight gain does not increase the risk of all types of severe 
maternal morbidity equally. For example, though excessive weight gain plausibly increases the 
risk of delivery complications (Cesarean section, heart failure, and so on), it probably does not lie 
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on the causal pathway to sickle cell anemia with crisis or amniotic fluid embolism. Future studies 
with adequate samples might consider performing analyses using specific indicators rather than a 
composite measure of severe maternal morbidity. 
Regarding limitations specific to our study, the first is related to our exposure definition. 
Misreporting of weight before pregnancy (which varies across prepregnancy BMI categories109) 
or at delivery may have led to misclassification of gestational weight gain. Though a 2017 
systematic review of 62 studies suggested that average reporting error did not largely bias 
associations between pregnancy-related weight and pregnancy outcomes,110 if in our sample there 
was differential misclassification of our exposure, our results may be biased. Second, if the missing 
data in this analysis varied by key covariates (missing not at random), our estimated association 
may be spurious. However, we explored the pattern of missing data and found that, while the data 
was not missing completely at random, there were no concerning patterns among key variables. 
Finally, others should exercise caution in applying these results to the general obstetric population 
in the U.S., especially community hospitals or facilities serving a population significantly different 
from this sample because the incidence of severe maternal morbidity varies by facility type and 
ethnic/ racial composition of the patient population.30,34 
Because pregnancy is a time when women have access to regular healthcare and are 
motivated to optimize their health,111 gestational weight gain is a potential target to decrease the 
risk of severe maternal morbidity. Clinicians can pair these specific findings alongside other 
literature on gestational weight gain and adverse perinatal outcomes to educate their patients on 
the importance of healthy weight gain and inform their decision-making for when intervention is 
warranted. These findings could also be incorporated as part of risk assessment tools at the time 
of delivery hospitalization. Gestational weight gain is likely just part of a constellation of factors 
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that increases one’s risk. To significantly reduce the burden that severe maternal morbidity places 
on healthcare systems, patients, and their families, we must continue to advocate for more holistic 
research on this topic, promote access to affordable healthcare, and strive for system-wide, 
collaborative approaches to better understand how high risk women can be identified and treated. 
3.6 Tables and Figures 
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Table 1 Characteristics of women delivering singleton infants at Magee-Womens Hospital in Pittsburgh, PA, 
2003-2012 (N=84,241) 
Maternal characteristic n(% of cohort) 
Overall 
Prepregnancy body mass index (BMI cutpoints) 
   Underweight 
   (<18.5kg/m2) 
4,096 (4.8) 
   Normal weight  
   (18.5-24.9kg/m2) 
43,709 (52) 
   Overweight (25.0-29.9kg/m2) 20,099 (24) 
   Obese (≥30.0kg/m2) 16,337 (19) 
Age (years) 
   <20 5,930 (7.0) 
20-30 38,086 (45) 
>30 40,225 (48) 
Race/ ethnicity 
   Non-Hispanic White 63,062 (75) 
   Non-Hispanic Black 16,540 (20) 
   Other  4,639 (5.5) 
Parity at conception 
   0 38,598 (46) 
   1 or more 45,643 (54) 
Marital status 
   Unmarried 33,450 (40) 
   Married 50,791 (60) 
Education 
   High school or less 25,694 (30) 
   Some college 19,477 (23) 
   College graduate 39,070 (46) 
Preexisting hypertension or diabetes 
   Yes 3,743 (4.4) 
   No 80,498 (96) 
Smoking during pregnancy 
   Yes 12,323 (15) 
   No 40,630 (85) 
Insurance 
   Private 43,611 (52) 
   Public/ Other 40,630 (48) 
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Table 2 Mean z-score among singleton pregnancies at delivery by maternal characteristic and gestational age 
at delivery. Magee-Womens Hospital in Pittsburgh, PA, 2003-2012 (N=84,241) 
Maternal characteristic 
Mean (SD) z-score at 
delivery 
Prepregnancy body mass index (BMI cutpoints) 
   Underweight (<18.5kg/m2) 0.10 (1.0) 
   Normal weight (18.5-24.9kg/m2) -0.14(1.0)
   Overweight (25.0-29.9kg/m2) -0.14 (1.0)
   Obese (≥30.0kg/m2) 0.03 (1.2)
Maternal age (years) 
   <20 -0.05 (1.1)
20-30 -0.06 (1.1)
>30 -0.14 (1.0)
Maternal race/ ethnicity 
   Non-Hispanic White -0.06 (1.0)
   Non-Hispanic Black -0.15 (1.2)
   Other  -0.37 (1.0)
Parity at conception 
   0 0.02 (1.1) 
   1 or more -0.19 (1.1)
Marital status 
   Unmarried -0.07 (1.2)
   Married -0.11 (1.0)
Maternal education 
   High school or less -0.11 (1.2)
   Some college -0.05 (1.1)
   College graduate -0.11 (0.99)
Preexisting hypertension or diabetes 
   Yes 0.09 (1.2) 
   No -0.11 (1.1)
Smoking during pregnancy 
   Yes -0.18 (1.2)
   No -0.08 (1.0)
Insurance 
   Private -0.08 (1.0)
   Public/ Other -0.11 (1.1)
a <11kg among normal weight, 9.5kg among overweight, and 3.3kg among obese women at 40 
weeks’ gestation.  
b 11-23kg among normal weight, 9.5-25kg among overweight, and 3.3-19kg among obese 
c >23kg among normal weight, >25kg among overweight, and >19kg among obese women. 
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Table 3 Incidence of severe maternal morbidity by maternal characteristic. Magee Women’s Hospital 
Pittsburgh, PA, 2003-2012 (N=84,241) 
Maternal characteristic 
Cases of severe maternal 
morbidity (unadjusted incidence) 
Overall 
Prepregnancy body mass index (BMI cutpoints) 
   Underweight (<18.5kg/m2) 69 (1.7) 
   Normal weight (18.5-24.9kg/m2) 700 (1.6) 
   Overweight (25.0-29.9kg/m2) 400 (2.0) 
   Obese (≥30.0kg/m2) 427 (2.6) 
Maternal age (years) 
   <20 145 (2.5) 
20-30 670 (1.8) 
>30 782 (1.9) 
Maternal race/ ethnicity 
   Non-Hispanic White 1034 (1.6) 
   Non-Hispanic Black 468 (2.8) 
   Other  95 (2.1) 
Parity at conception 
   0 794 (2.1) 
   1 or more 804 (1.8) 
Marital status 
   Unmarried 797 (2.4) 
   Married 800 (1.6) 
Maternal education 
   High school or less 637 (2.5) 
   Some college 391 (2.0) 
   College graduate 570 (1.5) 
Preexisting hypertension or diabetes 
   Yes 221 (5.9) 
   No 1377 (1.7) 
Smoking during pregnancy 
   Yes 259 (2.1) 
   No 1339 (1.9) 
Insurance 
   Private 698 (1.6) 
   Public/ Other 899 (2.2) 
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Figure 1 Adjusted, predicted risk of severe maternal morbidity by gestational weight gain z-score. 
Solid line represents point estimates, dashed lines represent 95% confidence intervals 
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Table 4 Cumulative incidence of severe maternal morbidity by gestational weight gain z-score category. Magee-Women’s Hospital. Pittsburgh, PA, 
2003-2012 (N=84,241) 
Gestational 
weight gain 
z-score category
n at risk 
Unadjusted risk 
(cases) 
Unadjusted RD 
(95% CI) 
Adjusted RD 
(95% CI) 
<-2 3,356 2.5 (86) 0.83 (0.21, 1.5) 0.60 (0.01, 1.2) 
-2 to <-1 10,161 1.8 (185) 0.13 (-0.22, 0.48) 0.07 (-0.29, 0.42) 
-1 to <0 30,298 1.7 (500) Reference Reference 
0 to <+1 29,783 1.9 (542) 0.21 (-0.04, 0.45) 0.12 (-0.14, 0.37) 
+1 to <+2 9,363 2.4 (234) 0.74 (0.33, 1.2) 0.49 (0.09, 0.89) 
≥+2 1,280 3.9 (50) 2.3 (1.0, 2.5) 1.8 (0.67, 2.9) 
40-week gestation equivalent weight gain for normal weight women: -2SD(7.0kg);
-1SD(11kg); 0SD(16kg); 1SD(23kg); 2SD(31kg)
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Table 5 Estimated number of excess cases of severe maternal morbidity per 100 delivery hospitalizations by 
select gestational weight gain z-scores. Overall delivery hospitalizations at Magee-Womens Hospital, 
Pittsburgh, PA, 2003-2012 (N=84,241) 
Gestational weight 
gain z-score category 
Adjusted risk per 100 delivery 
hospitalizations 
(95% confidence interval) 
Adjusted RD per 100 delivery 
hospitalizations 
(95% confidence interval) 
-3 SD 2.1 (1.7, 2.4) 0.30 (-0.07, 0.67) 
-2.5 SD 2.0 (1.7, 2.3) 0.22 (-0.07, 0.51) 
-2 SD 1.9 (1.7, 2.1) 0.14 (-0.07, 0.35) 
-1.5 SD 1.8 (1.7, 2.0) 0.06 (-0.08, 0.21) 
-1 SD 1.8 (1.6, 1.9) -0.01 (-0.10, 0.08)
-0.5 SD 1.7 (1.6, 1.8) -0.04 (-0.08, -0.002)
0 1.8 (1.6, 1.9) Reference 
+0.5 SD 1.6 (1.4, 1.7) 0.14 (0.08, 0.21) 
+1 SD 2.1 (1.9, 2.3) 0.38 (0.20, 0.56) 
+1.5 SD 2.4 (2.1, 2.7) 0.67 (0.33, 1.0) 
+2 SD 2.5 (2.1, 2.8) 1.0 (0.46, 1.5) 
+2.5 SD 3.1 (2.4, 3.8) 1.3 (0.58, 2.0) 
+3 SD 2.4 (2.5, 4.3) 1.6 (0.68, 2.6) 
40-week gestation equivalent weight gain for normal weight women: -2SD(7.0kg);
-1SD(11kg); 0SD(16kg); 1SD(23kg); 2SD(31kg)
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4.1 Abstract 
Background 
Gestational weight gain is a potentially modifiable risk factor for severe maternal 
morbidity, but there is no literature on the relationship between weight gain in the first half of 
pregnancy and severe maternal morbidity. 
Methods 
We used a retrospective cohort of 4,774 delivery hospitalizations that was sampled from a 
large cohort and augmented with data on serial weight gain measurements and severe maternal 
morbidity indicators at Magee-Womens Hospital in Pittsburgh, PA (2003-2011). Absolute risk 
measures were calculated by weighting the sample by inverse probability weights based on 
sampling by prepregnancy BMI category. We defined gestational weight gain at 16-19 weeks 
using prepregnancy BMI- and gestational-age adjusted z-scores to remove potential confounding 
by gestational age at delivery. We used multivariable logistic regression models, adjusted for 
prepregnancy BMI race/ ethnicity, maternal education, maternal age at delivery, preexisting 
hypertension or diabetes, and parity. We calculated predicted probabilities of adjusted risk 
differences of severe maternal morbidity for select z-scores and present results as the number of 
excess cases per 100 delivery hospitalizations. 
Results 
The cumulative incidence of severe maternal morbidity in this sample was 2.1% and was 
highest among those with z-scores near the mean and lowest in the tails of the distribution of 
weight gain (2.4/100 among those with a z-score of 0 and 1.6 and 1.2/ 100 among those with z-
scores of -2 and +2, respectively). After adjusting for known confounders, we found a similar 
trend; compared with a z-score of 0 (5.2kg at 19 weeks gestation among normal weight women), 
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z-scores of -2 and +2 were associated with -0.80(-2.7, 0.76) and -1.1(-2.4, 0.18) fewer cases of
severe maternal morbidity, respectively. 
Conclusions 
We found that weight gain at 16-19 weeks and risk of severe maternal morbidity followed 
a much different distribution than our previous results on total weight gain, likely due to 
differences in sample characteristics. These results should be applied with caution across the 
broader population of those at risk of severe maternal morbidity and should not overshadow our 
results on the association between total weight gain and severe maternal morbidity. The strongest 
evidence suggests that weight gain outside normal ranges is associated with moderate risk of 
severe maternal morbidity and should continue to be monitored throughout pregnancy given its 
association with other adverse, pregnancy-related outcomes. 
4.2 Introduction 
Pregnancy-related maternal mortality and morbidity have risen significantly in the U.S. 
over the past 2 decades1 and despite renewed focus on improving maternal outcomes,8,13,112 there 
has been little abatement in their incidence. Meaningful reduction in severe maternal morbidity 
will require multidisciplinary approaches, but identifying patient-level risk factors should remain 
part of any risk reduction strategy. Of the commonly cited, potent risk factors of severe maternal 
morbidity, most are modifiable only prior to conception (e.g. higher prepregnancy body mass 
index or preexisting medical conditions)29,36,89 or would require large-scale, population-level 
intervention (e.g. improving education and access to healthcare). Gestational weight gain, 
however, is one risk factor amenable to intervention during pregnancy.90,91 
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Previous work by our group and others suggest that suboptimal or excessive, total weight 
gain during pregnancy is associated with increased risk of severe maternal morbidity at delivery 
hospitalization.92 While understanding this relationship might prove valuable as part of risk 
assessment protocols during delivery hospitalization or as a tool to help educate pregnant women 
on the importance of healthy weight gain during pregnancy, using total weight gain as a primary 
exposure is not without limitations, even when rigorous methods are used.  
Total weight gain as an exposure does not account for the timing or trajectory of weight 
gain and, in the case of outcomes that are associated with hypertensive disorder during pregnancy 
(e.g. preeclampsia) or gestational diabetes mellitus, an association with total weight gain might be 
subject to reverse causation.113 Specifically, hypertension-related edema can result in rapid weight 
gain in the second half of pregnancy77,114,115 and gestational diabetes screening with subsequent 
clinical intervention may alter the trajectory of weight gain.75 New research is needed to address 
this gap in the literature by measuring weight gain before clinical manifestations of hypertensive 
disorders and gestational diabetes screening. Doing so would provide context to existing literature 
and better inform when and if intervention on weight gain is warranted. 
Our objective was to determine the association between weight gain at 16-19 weeks gestation 
and severe maternal morbidity. 
4.3 Methods 
Data source and sampling 
The data for this retrospective cohort were collected as part of a larger case-cohort study 
on gestational weight gain at Magee-Womens Hospital of the University of Pittsburgh Medical 
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Center in Pittsburgh, Pennsylvania. There were 114,736 singleton deliveries at Magee from 1998-
2010. In the original study, women were excluded if they were delivering multiple fetuses, had a 
gestational age <16 or >42 weeks, or did not have a prepregnancy weight measurement (n=80,812 
remaining). From these eligible records, 1,411 pregnancies were randomly sampled from each 
prepregnancy BMI category to form a subcohort for statistical comparisons. 
We augmented this dataset with information on serial weight gain measurements gathered 
via medical record abstraction. Standardized chart abstraction was performed by data collectors 
with uniform training, who entered data into a computer-assisted data entry system.116 A reliability 
study showed high inter-rater agreement, including for important variables such as maternal weight 
and gestational age. We dropped those observations with missing antenatal weight measurements. 
Finally, we merged with this dataset with diagnosis and procedure codes indicating the 
presence of severe maternal morbidity from the Magee Obstetric, Medical, and Infant (MOMI) 
database. MOMI is an electronic data repository comprised of information from admitting 
services, medical and birth records, as well as ultrasound and other ancillary systems. 
Administrators routinely code and clean the data as well as validate the stored data against medical 
records.  
Of the 8,466 pregnancies in the original subcohort, women were eligible for the present 
analysis if they delivered from 2003-2011 at 20-42 weeks gestation and had complete data on 
parity, infant sex, admission and discharge date, and administrative codes indicating severe 
maternal morbidity (n=6,160). Women were excluded if they no prenatal weight measurements 
(n=184) or no weight measurement in the gestational age window of interest (16+0 weeks to 19+6 
weeks, n=308). If women had more than 1 weight measurement in this window, the one closest to 
19 weeks was used. Finally, women who had missing data in key variables were excluded from 
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the analysis (n=849). Appendix F  presents the sampling fractions by prepregnancy BMI category. 
The final analytic sample consisted of 4,774 delivery hospitalizations. The University of Pittsburgh 
Institutional Review Board approved this study as exempt because no identifiable information was 
used. 
Exposure definition 
The exposure window of interest was 16+0 to 19+6 because it precedes the clinical onset 
of hypertensive disorders of pregnancy and gestational diabetes screening. Maternal weight at 16-
19 weeks was collected by hospital staff at the corresponding prenatal visit.  Maternal 
prepregnancy weight and height were ascertained via self-report at the first prenatal visit. 
Prepregnancy BMI was calculated and categorized as underweight (<18.5 kg/m2), normal weight 
(18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2), and obese ((≥30 kg/m2).96 Weight gain was 
defined as maternal weight at 16-19 weeks minus prepregnancy weight. If there were more than 
one weight measurement from 16-19 weeks, we chose the most recent. We converted each 
gestational weight gain to gestational age-specific z-scores for each prepregnancy body mass index 
(BMI) category using gestational-age and BMI specific charts, which produces a weight gain 
measure that is independent of gestational age.98,99,117 We also modeled gestational weight gain z-
scores as a categorical variable using -2 through +2 SD as cutpoints. Weight gain z-scores <-4 or 
>+4 were considered outliers and excluded. For ease of interpretation, we provide absolute weight 
gain (kg) at 19 weeks for a range of z-scores.  
Outcome definition 
We defined severe maternal morbidity as the presence of the 21 Centers for Disease 
Control and Prevention diagnosis or procedure ICD-9 codes (Appendix B), maternal intensive care 
unit admission, or maternal prolonged postpartum length of stay (>3 days for vaginal deliveries 
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and >5 days for Cesarean deliveries, corresponding to >3 standard deviations beyond the mean 
length of stay). These criteria have been used in a variety of administrative data research on severe 
maternal morbidity and have been shown to perform reasonably well against a gold standard of 
chart review.30 
Confounders 
We selected confounders based on theory-based causal graphs and because of the limited 
sample size, created a parsimonious model to stabilize our statistical models by removing 
confounders that changed our effect estimates by <7%. The full list of confounders included: 
mother’s prepregnancy BMI, race/ ethnicity, maternal age at delivery, education, marital status, 
primary method of payment, preexisting hypertension or diabetes, parity, and smoking during 
pregnancy. The parsimonious model consisted of prepregnancy BMI (4-knot restricted cubic 
spline), race/ ethnicity (non-Hispanic White, non-Hispanic Black, and other), maternal education 
(less than high school, some college, or college graduate), maternal age at delivery (3-knot 
restricted cubic spline), preexisting hypertension or diabetes (yes/ no), and parity (nulliparous or 
1+ previous birth). Confounders were set to population means and included in the final model. 
Statistical analysis 
Unadjusted risk measures were calculated after weighting the cohort by the inverse of the 
sampling fractions. To estimate the association between gestational weight gain at 16-19 weeks 
and severe maternal morbidity, we used multivariable logistic regression models with generalized 
estimating equations and an exchangeable correlation structure to account for 99 repeated 
pregnancies in the dataset. Denominators were based on all delivery hospitalizations. Following 
model estimation, we calculated the predicted probabilities, risk differences, and corresponding 
95% confidence intervals of severe maternal morbidity by selected weight gain z-scores from -3 
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standard deviations to +3 standard deviations. We presented these results as the number of excess 
cases of severe maternal morbidity per 100 delivery hospitalizations. We also performed a series 
of sensitivity analyses where we modified our exposure window (10-13 weeks, 24-28 weeks, and 
16-19 weeks to delivery) to test whether the association with severe maternal morbidity differed.
We also tested the association between total gestational weight gain and severe maternal morbidity 
among women who had both, weight measurements at delivery hospitalization and serial weight 
gain measurements. 
4.4 Results 
Most of the women in this sample were normal weight, >30 years of age, non-Hispanic 
White, multiparous, married, holders of college degrees, and used private insurance as their 
primary method of payment (Table 6). The incidence of preterm birth was 9.5%. Less than 5% has 
preexisting hypertension or diabetes and 13% reported smoking during pregnancy.  
There were no meaningful differences in the incidence of severe maternal morbidity or the 
prevalence of key maternal variables between this cohort with that of the larger cohort from which 
it was sampled (Appendix I). Appendix F presents the sample size and sampling probabilities of 
the eligible cohort and this sample. 
The median (interquartile range) gestational weight gain at 16-19 weeks was 4.5 (3.2, 6.8) 
kg for underweight women, 4.5(2.3, 6.8) for normal weight women, 4.5 (2.3, 8.0) for overweight 
women, and 2.8 (0.0, 6.4) for obese women. Of the weight measurements used, 27% were from 
19 weeks, 27% from 18 weeks, 24% from 17 weeks, and 22% from 16 weeks. Women tended to 
gain more weight at 16-19 weeks if they were greater than 30 years of age at conception, delivered 
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preterm, were non-Hispanic White, had preexisting hypertension or diabetes, or used private 
insurance. There were smaller differences in terms of marital status, education, and smoking 
during pregnancy (Table 7). Normal weight women tended to gain the least amount of weight at 
16-19 weeks with women in the other groups having similar, mean weight.
The cumulative incidence of severe maternal morbidity in this sample was 2.1% (n=96). 
Roughly 72% of the severe maternal morbidity cases in this sample had at least 1 of the 21 CDC 
indicators of maternal morbidity, 32% were admitted to the ICU, and 25% had a prolonged 
postpartum length of stay. Women were more likely to have a severe maternal morbidity if they 
had a higher BMI before pregnancy, were older, delivered preterm, were non-Hispanic Black, had 
preexisting hypertension or diabetes, or reported smoking during pregnancy (Table 8). There were 
smaller differences in terms of parity, education, and insurance. The unadjusted risk followed an 
inverted-U distribution, with those with z-score <-1 and >=1 having the lowest risk (1.4/100 and 
1.2/100, respectively). Those with z-scores -1 to <0 were at the highest risk (2.3/100 delivery 
hospitalizations, Table 9).   
After adjusting for confounders, we found a similar relationship between weight gain z-
score at 16-19 weeks and risk of severe maternal morbidity at delivery hospitalization (Figure 2). 
Compared with a z-score of 0, z-scores of -3 and +3 were associated with 1.2 (-0.74, 3.1) and 1.6 
(-0.07, 3.0) fewer cases of severe maternal morbidity (Table 10). Sensitivity analyses are shown 
in Appendix J. Overall, we found that when weight was measured before 20 weeks gestation, the 
relationship with severe maternal morbidity followed the same, inverted-U distribution. For weight 
gain after 20 weeks (i.e. 24-28 weeks, weight gain the second half of pregnancy, and total weight 
gain), the relationship followed an a gradual, decreasing linear patter, with those with low weight 
gain being at the highest risk and those with high weight gain being at the lowest risk. 
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4.5 Discussion 
In this analysis of 4,774 delivery hospitalizations augmented with data on serial weight 
gain measurements, we found that the association between weight gain at 16-19 weeks gestation 
and severe maternal morbidity followed an inverted U pattern, with risk decreasing above and 
below the mean weight gain z-score.  
Our results are unexpected considering our other work on the association between total 
gestational weight gain and risk of severe maternal morbidity. Although there are no known studies 
on the association between early weight gain in pregnancy and risk of severe maternal morbidity, 
there are several possible explanations for these discordant results. There were no meaningful 
differences in key, maternal variables between the eligible cohort, the randomly sampled cohort, 
and our final analytic sample. We also compared the current cohort with the cohort from our 
previous analysis on total gestational weight gain. We found no significant differences between 
these variables among women in this sample who did not have a severe maternal morbidity, but 
we found notable differences in maternal characteristics among those with the presence of a severe 
maternal morbidity; however, because this was a cohort study, these differences are less 
informative than if it were a case-control study. Furthermore, there were no substantial differences 
in the type of severe maternal morbidity experienced between the cohorts. Conversely, the women 
for whom serial weight gain measurements are available might not be representative of the 
population at Magee or the broader statewide or U.S. population. These data are not regularly or 
consistently entered across facilities. The facilities who regularly use and upload serial weight 
measurements are likely different than those who do not. This would substantively impact our 
results, though without further analysis, we cannot predict the direction and magnitude that it 
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would change the association between early weight gain and risk of severe maternal morbidity. 
These limitations also impair our ability to compare our total weight gain results with these results. 
We performed a series of sensitivity analyses, varying the exposure window, including the 
rate of weight gained in the second half of pregnancy, 10-13 weeks gestation, 24-28 weeks 
gestation, as well as replicated the analyses from our total weight gain manuscript among women 
who had both, serial weight measurements and weight measurements at delivery, shown in 
Appendix P. There was an inverse association between the rate of weight gain in the second half 
of pregnancy and risk of severe maternal morbidity at delivery hospitalization, with the highest 
risk among those with lower weight gain and the lowest risk among those with higher (3.5/100 
delivery hospitalizations in the lowest quartile and 1.5/100 in the highest). The association between 
weight gain at 24-28 weeks as well as total weight gain in this cohort and severe maternal 
morbidity followed a similar pattern. Weight gain at 10-13 weeks gestational followed a similar 
pattern as our primary analysis (an inverted U risk distribution). If there were no underlying 
differences in the characteristics of the cohorts, we would expect the association between total 
weight gain and risk of severe maternal morbidity to be similar.  
Even though in this sample we observed the lowest risk among those who gained the most 
weight, we cannot recommend gaining higher weight because of the strong evidence from our 
previous research and other efforts that high weight gain is associated with myriad adverse 
pregnancy outcomes for mother and child. However, as supported by the Institute of Medicine, 
clinicians must determine optimal weight for patients within the broader context of a woman’s 
health profile, the consistency of her and the fetus’s growth during pregnancy, and the 
development of any adverse health markers during gestation. In addition to confirming these 
findings in large, diverse samples, future research with these data should explore differences 
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between the facilities from which serial weight gain measurements are provided because they are 
not uniformly or consistently included across facilities. Along with this exploration, we should 
determine if any differences in the phenotype of severe maternal morbidity exists between low and 
high-risk pregnancies. This might help with not only reconciling the different results between the 
total and early weight gain findings, but also to inform planning efforts regarding delivery location 
and resource allocation.  
Our findings must be interpreted within the context of the study’s limitations. The principal 
limitation of this study is potential selection bias. As mentioned, it is plausible and likely that the 
women in this sample are not representative of the larger population of women who delivery at 
Magee nor the general population. The facilities from which these data are drawn do not report 
data with uniformity and consistency, often due to different usages of electronic medical record 
systems. In addition to facility-level bias, women with data on serial weight measurements might 
be 1) more compliant and more motivated to maintain a healthy weight throughout pregnancy or 
2) have these data available because they were identified as high risk and required more frequent
prenatal visits.118 Though our data do not suggest any concerning differences in key variables, we 
showed that maternal characteristics among those who faced severe maternal morbidity are 
different than other, large, population-based studies.32,119 As such, we must interpret these findings 
cautiously and without further exploration of the specific patient characteristics of the clinics from 
which these data are drawn, cannot determine the extent to which our data is biased. Future 
research should attempt to remedy this limitation by collecting these data and performing a formal 
bias analysis, if possible. Secondly, as with many other studies that used administrative data to 
study severe maternal morbidity, an overarching limitation of this research is that our outcome 
definition was not based on a gold standard of chart review. However, external validation studies 
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have found that a multi-factor definition used here performed reasonably well against the gold 
standard mentioned above. If we follow current screening guidelines, which recommend that 
severe maternal morbidity be defined using either >4 units of blood product of ICU admission as 
the principal screening tool,21 it is likely that we overestimated the incidence in this sample because 
we did not have data on the specific volume of blood administered. It is also possible that we failed 
to identify some cases of severe maternal morbidity due to false negatives in this administrative 
database. We expect the misclassification is minimal, but without a formal bias analysis, we cannot 
determine whether potential misclassification was differential. Another limitation that is pervasive 
in the literature is our window of outcome ascertainment was limited to delivery hospitalization. 
Severe maternal morbidity can occur during pregnancy, delivery, or postpartum. Not including 
these cases would lead to underestimation of the incidence and depending on the underlying 
characteristics of the cases, bias our associations towards or away from the null. We also used a 
relatively small sample (n=96 cases of severe maternal morbidity), which prevented us from 
performing more robust sensitivity analyses of our outcome definition and exploring the 
associations between individual indicators of severe maternal morbidity, as we did in our analysis 
of total weight gain. However, in our previous work, we found no meaningful differences in our 
effect estimates when we excluded blood transfusion, ICU admission, or extended postpartum 
length of stay, though we recognize that given the differences in samples, there might be 
differences according to outcome definition. Though less likely than the mechanisms discussed 
above, it is possible that these associations are due to other factors, such as underlying physiologic 
mechanisms by the type of weight gained throughout pregnancy, potential mediating effects that 
could have obscured the direct association, or unmeasured factors such as the quality of prenatal 
care.107 Finally, because we performed analyses on complete cases only, it is possible that our 
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associations could be biased if data was missing not at random. While we confirmed that missing 
data was not missing completely at random, we did not observe any patterns in key variables that 
we believe would lead to bias. Additionally, we decided that the benefit of imputing so few 
variables did not outweigh the complexity and risk of possible misspecification of the imputation 
model. 
Gestational weight gain is an attractive intervention target for reducing the incidence severe 
maternal morbidity because it is one of the only known risk factors that is modifiable during 
pregnancy. In this sample, because the potential of selection bias, we should adopt these results 
cautiously. Future research efforts must confirm our findings, ideally in populations that are similar 
to the general population at risk of severe maternal morbidity, but clinicians should continue to 
use current recommendations alongside sound clinical judgement to balance risk factors with 
optimal weight gain during pregnancy.107 Since severe maternal morbidity is a heterogeneous 
outcome with many different phenotypes, in addition to confirming our results, future research 
should examine specific indicators of severe maternal morbidity and determine if opportunities 
exist for improvement in care or for early risk identification. Given not all women access 
healthcare before pregnancy, understanding the risk factors that are amenable to intervention 
during pregnancy should be a top research priority in reducing the incidence of severe maternal 
morbidity. 
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4.6 Tables and Figures 
Table 6 Characteristics of women with serial antenatal weight measurements delivering singleton infants. 
Magee-Womens Hospital, Pittsburgh, PA, 2003-2011 
Characteristic 
Frequency of sample (%) 
Unweighted 
(N=4,774) 
Weighted 
(N=80,236) 
Prepregnancy body mass index (BMI 
cutpoints) 
   Underweight (<18.5kg/m2) 800 (17) 2,000 (2.5) 
   Normal weight (18.5-24.9kg/m2) 811 (17) 38,618 (48) 
   Overweight (25.0-29.9kg/m2) 787 (16) 22,485 (28) 
   Obese (≥30.0kg/m2) 2,376 (50) 17,133 (21) 
Maternal age (years) 
   <20 280 (5.9) 4,965 (6.2) 
20-30 2,177 (46) 34,301 (43) 
>30 2,317 (49) 40,970 (51) 
Gestational age at delivery 
   Term (≥37 weeks) 4,280 (90) 72,612 (91) 
   Preterm (<37 weeks) 494 (10) 7,626 (9.4) 
Maternal race/ ethnicity 
   Non-Hispanic White 3,602 (75) 62,758 (78) 
   Non-Hispanic Black 971 (20) 13,534 (17) 
   Other 201 (4.2) 3,944 (4.9) 
Parity 
   No births 2,103 (44) 35,889 (45) 
   Previous birth 2,671 (56) 44,347 (55) 
Marital status 
   Unmarried 1,898 (39) 28,402 (35) 
   Married 2,921 (61) 52,196 (65) 
Maternal education 
   Less than high school 1,438 (30) 20,700 (26) 
   High school or some college 1,283 (27) 19,531 (24) 
   College graduate 2,053 (43) 40,004 (50) 
Preexisting hypertension or diabetes 
   Yes 410 (8.6) 3,974 (5.0) 
   No 4,364 (91) 76,264 (95) 
Smoking during pregnancy 
   Yes 715 (15) 10,239 (13) 
   No 4,059 (85) 69,997 (87) 
Insurance 
   Private 2,549 (53) 44,647 (56) 
   Public/ Other 2,225 (47) 35,589 (44) 
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Table 7 Mean z-score by characteristics of women with serial antenatal weight measurements delivering 
singleton infants. Magee-Womens Hospital, Pittsburgh, PA, 2003 2011 (N=4,774) 
Characteristic 
Mean (SD) z-score at 16-19 
weeks gestation 
Prepregnancy body mass index (BMI cutpoints) 
   Underweight (<18.5kg/m2) 0.15 (1.1) 
   Normal weight (18.5-24.9kg/m2) -0.07 (1.1)
   Overweight (25.0-29.9kg/m2) 0.15 (0.98)
   Obese (≥30.0kg/m2) 0.21 (0.91)
Maternal age (years) 
   <20 -0.15 (1.1)
20-30 0.01 (1.1)
>30 0.12 (0.94)
Gestational age at delivery 
   Term (≥37 weeks) 0.04 (1.0) 
   Preterm (<37 weeks) 0.22 (1.2) 
Maternal race/ ethnicity 
   Non-Hispanic White 0.08 (0.98) 
   Non-Hispanic Black 0.04 (1.2) 
   Other -0.22 (1.1)
Parity 
   No births 0.04 (1.0) 
   Previous birth 0.07 (1.0) 
Marital status 
   Unmarried 0.07 (1.2) 
   Married 0.05 (0.96) 
Maternal education 
   Less than high school 0.05 (1.1) 
   High school or some college 0.07 (1.1) 
   College graduate 0.05 (0.93) 
Preexisting hypertension or diabetes 
   Yes 0.55 (1.0) 
   No 0.03 (1.0) 
Smoking during pregnancy 
   Yes 0.06 (1.1) 
   No 0.06 (1.0) 
Insurance 
   Private 0.08 (0.96) 
   Public/ Other 0.02 (1.1) 
59 
Table 8 Cumulative incidence of severe maternal morbidity among women with serial antenatal weight 
measurements delivering singleton infants. Magee-Womens Hospital, Pittsburgh, PA, 2003-2011 (N=4,774) 
Characteristic 
Cases of severe maternal morbidity 
(unadjusted risk) 
Prepregnancy body mass index (BMI 
cutpoints) 
   Underweight (<18.5kg/m2) 4 (0.50) 
   Normal weight (18.5-24.9kg/m2) 16 (2.0) 
   Overweight (25.0-29.9kg/m2) 16 (2.0) 
   Obese (≥30.0kg/m2) 60 (2.4) 
Maternal age (years) 
   <20 7 (2.2) 
20-30 35 (1.2) 
>30 54 (2.7) 
Gestational age at delivery 
   Term (≥37 weeks) 69 (1.7) 
   Preterm (<37 weeks) 27 (5.8) 
Maternal race/ ethnicity 
   Non-Hispanic White 64 (2.0) 
   Non-Hispanic Black 29 (2.6) 
   Other 3 (1.6) 
Parity 
   No births 51 (2.3) 
   Previous birth 45 (1.9) 
Marital status 
   Unmarried 43 (2.3) 
   Married 53 (1.9) 
Maternal education 
   Less than high school 35 (2.2) 
   High school or some college 18 (1.7) 
   College graduate 43 (2.1) 
Preexisting hypertension or diabetes 
   Yes 13 (4.2) 
   No 83 (1.9) 
Smoking during pregnancy 
   Yes 13 (1.0) 
   No 83 (2.2) 
Insurance 
   Private 51 (2.2) 
   Public/ Other 45 (1.9) 
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Table 9 Association between gestational weight gain z-score category at 16-19 weeks and severe maternal 
morbidity at delivery hospitalization. Magee-Women’s Hospital, Pittsburgh, PA, 2003-2011 (N=4,774) 
Gestational weight 
gain z-score 
category 
n at risk Cases 
Unadjusted 
risk (95% CI) 
Adjusted risk 
(95% CI) 
Adjusted RD 
(95% CI) 
<-1 485 9 1.4 (0.04, 2.7) 1.6 (0.05, 3.1) -0.72 (-2.6, 1.2)
-1 to <0 1,480 28 2.3 (1.2, 3.4) 2.3 (1.2, 3.4) Reference
0 to <+1 2,027 45 2.4 (1.5, 3.4) 2.4 (1.4, 3.3) 0.07 (-1.4, 1.6)
≥+1 782 14 1.2 (0.38, 1.9) 1.1 (0.36, 1.8) -1.2 (-2.6, 0.14)
Figure 2 Adjusted, predicted risk of severe maternal morbidity by gestational weight gain z-score. 
Solid lines indicate point estimates and dashed lines, 95% confidence intervals. Pittsburgh, PA. N=4,774 
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Table 10 Adjusted risk difference of severe maternal morbidity by gestational weight gain z-score at 16-19 
weeks gestation. Magee-Womens Hospital, Pittsburgh, PA, 2003-2011 (N=4,774) 
Gestational weight 
gain z-score at 16-19 
weeks 
Adjusted risk per 100 delivery 
hospitalizations (95% 
confidence interval) 
Number of excess cases per 100 
delivery hospitalizations (95% 
confidence interval)  
-3 SD 1.2 9-0.42, 2.8) -1.2 (-3.1, 0.74)
-2.5 SD 1.4 (-0.12, 2.9) -1.0 (-2.7, 0.76)
-2 SD 1.6 (0.22, 2.9) -0.80 (-2.3, 0.74)
-1.5 SD 1.8 (0.66, 2.9) -0.58 (-1.8, 0.66)
-1 SD 2.0 (1.1, 2.9) -0.35 (-1.2, 0.52)
-0.5 SD 2.2 (1.5, 3.0) -0.11 (-0.53, 0.30)
0 2.4 (1.6, 3.1) Reference 
0.5 SD 2.2 (1.5, 2.9) -0.16 (-0.51, 0.19)
1 SD 1.9 (1.2, 2.5) -0.50 (-1.3, 0.26)
1.5 SD 1.5 (0.73, 2.3) -0.84 (-1.9, 0.25)
2 SD 1.2 (0.31, 2.2) -1.1 (-2.4, 0.18)
2.5 SD 1.0 (-0.0006, 2.0) -1.4 (-2.8, 0.07)
3 SD 0.80 (-0.21, 1.8) -1.6 (-3.0, -0.07)
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5.1 Abstract 
Objective 
To determine the population-attributable fraction (PAF) of potentially modifiable risk 
factors for severe maternal morbidity. 
Methods 
We used a retrospective cohort of 86,260 delivery hospitalizations from Magee-Womens 
Hospital, Pittsburgh, PA for this analysis (2003-2012). Severe maternal morbidity was defined as 
any of the following: Centers for Disease Control and Prevention International Classification of 
Diseases 9th  Revision diagnosis and procedure codes for the identification of maternal morbidity; 
prolonged postpartum length of stay; or maternal intensive care unit admission.  We used 
multivariable logistic regression with generalized estimating equations to estimate the association 
of prepregnancy overweight or obesity, maternal age ≥35 years, preexisting hypertension, 
preexisting diabetes, excessive gestational weight gain, smoking, education, and marital status 
with severe maternal morbidity. We calculated the PAF for each risk factor.  
Results 
The overall rate of severe maternal morbidity was 2.0 per 100 delivery hospitalizations. 
Overweight and obesity, maternal age ≥35 years, preexisting hypertension, and lack of a college 
degree had PAF ranging from 6% to 13%. If all risk factors were eliminated, 36% of cases could 
have been prevented. Modest reductions in the prevalence of excessive BMI, high gestational 
weight gain, and advanced maternal age, and prepregnancy diabetes had minimal impact on 
preventing severe maternal morbidity. Smoking during pregnancy and marital status were not 
associated with severe maternal morbidity. 
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Conclusions 
Our data suggest maternal morbidity can be reduced somewhat by modifying common, 
individual-level risk factors. Nevertheless, most cases were not attributable to the risk factors we 
examined. These data support the need for large studies of patient-, provider-, system- and 
population-level factors to identify high-impact interventions to reduce maternal morbidity. 
5.2 Introduction 
Maternal mortality has more than doubled in the United States (U.S.) over the past 30 years 
and occurs more frequently in the U.S. than in any other high-income nation.12,23,120 While an 
important public health problem, maternal mortality remains rare—roughly 0.017 deaths per 100 
live births in the U.S. annually– making it a difficult subject for epidemiologic studies. Severe 
maternal morbidity is more common (approximately 1.4 cases per 100 delivery hospitalizations), 
and shares risk factors and etiologies with maternal mortality.1 Thus, severe maternal morbidity 
can serve as a reasonable proxy for maternal mortality in epidemiologic studies. Severe maternal 
morbidity also leads to prolonged hospital stays, increased need for rehabilitation, and increased 
health care costs.23,119  
Public health interventions that target modifiable risk factors may reduce severe maternal 
morbidity. Prepregnancy overweight and obesity, advanced maternal age, preexisting hypertension 
and diabetes, and smoking have all been associated with severe maternal morbidity.29,31,33,36,39,42-
44,47,121 Preliminary evidence by our group suggests that high, total gestational weight gain might 
also increase the risk of severe maternal morbidity. Social determinants of health such as maternal 
education and marital status may also be important leverage points for improving maternity 
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care.122,123 The extent to which these risk factors contribute to the overall burden of severe maternal 
morbidity is not known, but quantifying this burden would help to identify priority areas for 
maternal morbidity prevention efforts in the U.S. Our objective was to determine the population-
attributable fraction of potentially modifiable, individual-level risk factors and estimate the 
proportion of severe maternal morbidity that could be prevented if these risk factors were 
eliminated or reduced to a level that may be achievable. 
5.3 Methods 
Data source 
We used an administrative database to identify all deliveries including 20 to 42 weeks 
gestation from January 1, 2003 to May 31, 2012 at Magee-Womens Hospital, Pittsburgh, 
Pennsylvania (N=86,429). The database includes information on maternal, fetal and neonatal 
outcomes from electronic and medical record data.  Administrators code, clean, and store the data 
as well as validate it against medical records. We excluded 166 higher order pregnancies (triplets 
or higher) and 3 records that were missing data on infant sex, parity, or admission or discharge 
date. A total of 86,260 delivery hospitalizations were included in the final analytic sample. The 
University of Pittsburgh Institutional Review Board approved this study. 
Exposure definitions 
Maternal prepregnancy weight and height were ascertained via self-report at the first 
prenatal visit. Prepregnancy body mass index (BMI) was calculated and categorized as 
underweight (<18.5 kg/m2), normal weight (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2), and 
obese (≥30.0 kg/m2).124 Maternal weight at delivery was collected by hospital staff using either the 
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last measured weight in the prenatal records or the weight recorded upon admission to labor and 
delivery.125 Total gestational weight gain (kg) was standardized into gestational-age-specific z-
scores and then classified as ‘below’, ‘within’, or ‘above’ the Institute of Medicine 
recommendations based on pregravid BMI category.107,126 Preexisting hypertension and diabetes 
were based on ICD-9 codes. Maternal age, smoking status, maternal education and marital status 
were based on self-report. We defined advanced maternal age as either ≥35 years or  ≥40 years of 
age depending on the population attributable fraction calculation. We categorized maternal 
education as less than high school, some college, or college graduate and marital status as married 
or unmarried. 
Outcome definition 
We defined severe maternal morbidity as the presence of the following: any of the 21 CDC 
disease and procedure codes for identification of severe maternal morbidity (Appendix B), 
intensive care unit admission, prolonged postpartum length of stay (defined as >3 standard 
deviations beyond the mean length of stay: >3 days for vaginal deliveries and >5 days for Cesarean 
deliveries). The CDC criteria have been widely used in administrative data research, and this 
multipronged definition was found to perform well against a gold standard of chart review.30   
Missing data 
Of 86,260 delivery hospitalizations, 24% of the sample was missing prepregnancy weight 
or height; 8.5% delivery weight; 3.6% length of stay; and less than 1% maternal education, ICU 
admission status, and race/ethnicity. We use multiple imputation with chained equations to address 
these missing data. This method allowed us to specify unique, conditional distributions for each 
imputed variable. This approach is effective in addressing data that are missing up to 50% of 
values.102 After we log transformed all continuous variables, we jointly imputed maternal height, 
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prepregnancy weight, delivery weight, length of stay, education, and race using data on maternal 
identifier, census tract of residence, preexisting hypertension, preexisting diabetes, year of 
delivery, route of delivery, maternal status at discharge, fetal malformation, use of assistive devices 
during delivery, maternal age, smoking during pregnancy, parity, plurality, gestational diabetes, 
method of payment, marital status, fetal death, and gestational age at delivery. 
Statistical analysisWe used multivariable logistic regression with generalized estimating 
equations to estimate the association between each risk factor and severe maternal morbidity. We 
specified an exchangeable correlation structure to account for the correlation among pregnancies 
from the same woman (n=12,140 women with more than one pregnancy during the study period). 
Denominators were based on all delivery hospitalizations during the specified time period. Since 
we were simultaneously evaluating eight risk factors of interest, the final regression models 
included all risk factors as well as potential confounders: race (non-Hispanic White, non-Hispanic 
Black, and other), insurance (private, public), parity (nulliparous/ multiparous), and plurality 
(singleton or twin), which were selected using theory-based causal graphs.127  
We calculated the population-attributable fraction and 95% confidence intervals for each 
risk factor of interest using the “punaf” postestimation user-written command in STATA version 
14. We approximated the proportion of severe maternal morbidity in this sample that may be
attributed to prepregnancy overweight or obesity, advanced maternal age (≥35 years or ≥40 years 
of age), preexisting hypertension, preexisting diabetes, excessive gestational weight gain, and 
smoking during pregnancy using the following formula: 
𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑎𝑡𝑡𝑟𝑖𝑏𝑢𝑡𝑎𝑏𝑙𝑒 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 =
𝑃(𝐷) −  ∑ P(D|C,  E)P(C) 𝑐
𝑃(𝐷) 
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where ‘P(D)’ is the mean probability of disease in the population over a specified time interval 
and ‘P(D|C, E)P(C)’ is the marginal conditional probability of disease given an alternate exposure, 
averaged over strata of other risk factors or confounders.80 To calculate the population-attributable 
fraction, we assume that the relationship between each exposure and severe maternal morbidity 
was causal, that any lack of independence between risk factors is accounted for in our statistical 
models, and that the risk factors of interest are amenable to intervention. All other variables were 
set to their respective means.128  
We first calculated the population-attributable fraction associated with each individual risk 
factor.  This indicates the proportion of cases that could be prevented if the individual risk factor 
were eliminated-- all overweight and obese women were normal weight, all women were less than 
35 years of age at delivery, there were no preexisting hypertension, diabetes or tobacco use, and 
all women gained an amount of weight that was within the 2009 Institute of Medicine guidelines.  
We were also interested in the number of cases of maternal morbidity that could be prevented by 
more realistic reductions in risk factors, particularly in prepregnancy BMI.  Thus, we estimated 
the proportion of cases that could be prevented by reducing prepregnancy BMI by 3.5 kg/m2 among 
overweight and obese women, a reduction that reflects the change in BMI among women enrolled 
in diet and exercise interventions.129 We also tested the effect of all women being less than 40 
years of age at the time of delivery. Finally, we estimated the PAF due to all of the examined risk 
factors which corresponds to the estimated proportion of cases prevented by eliminating all risk 
factors simultaneously. 
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5.4 Results 
Most women in this sample were non-Hispanic White, married, multiparous, and used 
private insurance as their primary method of payment (Table 11). Twin pregnancies accounted for 
2.2% of the sample. Approximately 44% of women were either overweight or obese before 
pregnancy. The mean maternal age at delivery (standard deviation[SD]) was 29 (6.1) years. The 
overall mean (SD) gestational weight gain among singletons and twins was 15 (7.0) kg and 17 
(8.0) kg, respectively, with 17% of women gaining below the Institute of Medicine 
recommendations for total weight gain and 57% gaining above the guidelines.  
The unadjusted risk of severe maternal morbidity was 2.0 per 100 delivery hospitalizations. 
Of the 1,739 cases of severe maternal morbidity, 905 were defined based on the Centers for Disease 
Control and Prevention Criteria alone, 200 on ICU admission alone, and 250 on having an 
extended postpartum length of stay alone (Appendix B). Women were more likely to experience a 
severe maternal morbidity if they were overweight or obese, Non-Hispanic black, or ≤20 or 35 
years old, or had less than college education, gestational weight gain outside the Institute of 
Medicine guidelines, public insurance, a twin gestation, or preexisting hypertension or diabetes 
(Table 11). 
Overweight and obesity, maternal age 35 years, and preexisting hypertension had similar 
PAF, ranging from 6.0% to 7.1%, although precision around these estimates varied (Table 12). 
Gestational weight gain had a PAF of 5.8%, but our estimate was only marginally precise (95% 
CI: -0.42, 12). Preexisting diabetes had a low PAF of 2.4% (95% CI: 1.4, 3.4%). Lack of a college 
education had the highest PAF of all risk factors in our study—13% (95% CI: 5.7%, 19%), 
although the estimate was imprecise. Tobacco use and marital status were not associated with 
70 
severe maternal morbidity. All the studied risk factors combined had a total PAF of 36% (95% CI: 
14%, 53%) for severe maternal morbidity (Table 12). Thus, eliminating all the risk factors 
simultaneously would prevent an estimated 626 cases of severe maternal morbidity during the ten-
year study period.  
We also evaluated alternative risk reduction scenarios for maternal overweight and obese 
and advanced maternal age. A 3.5 kg/m2 reduction in BMI for overweight and obese women would 
prevent 3.9% (1.4%, 6.4%) of severe maternal morbidity cases in this group. If all women were 
less than age 40 at delivery we estimate we could prevent 1.8% (0.74%, 2.9%) of cases. 
5.5 Discussion 
The changing demographics of pregnant women is frequently cited as contributing to the 
rise in severe maternal morbidity —pregnant women are older, have higher prepregnancy BMI, 
and often begin pregnancy with more complex medical conditions.22,121 Our data suggest that 
prepregnancy overweight and obesity, advanced maternal age, preexisting hypertension, and 
excessive gestational weight gain each contribute to approximately 6% of the cases of severe 
maternal morbidity. Overall, this suggests that focusing public health efforts on a single risk factor 
will have a modest impact on maternal morbidity. Importantly, the PAF is similar between these 
disparate risk factors because factors that are common, such as prepregnancy overweight and 
obesity (44% of cohort), have modest risk ratios [1.1(1.0,1.3)] while risk factors with more robust 
risk ratios such as chronic hypertension [2.4 (2.0,2.8)] are uncommon (3.5% of cohort).  
We also examined two important social determinants of health. Interestingly, while marital 
status was not associated with severe maternal morbidity, lack of a college education had the 
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highest attributable fraction of all risk factors examined. Examining social determinants of health 
is a particularly important for this outcome given the profound racial disparities in maternal 
morbidity and mortality.130  The relatively large PAF associated with maternal education is not 
surprising. A 2013 report from the Institutes of Medicine cited the combination of societal factors 
such as education and unhealthy behavior as the leading explanations for health disadvantage.131  
If all the risk factors we examined were eliminated from the population, approximately one 
in three cases of severe maternal morbidity could have been prevented. This level of risk reduction 
is unrealistic, however, and our data support a more somber conclusion with regards to realistic 
risk reduction. When we estimated the PAFs associated with achievable risk reduction—a decrease 
of BMI by 3.5 units or shifting the age at delivery to less than 40 years of age —the PAFs were 
small and the number of cases of severe maternal morbidity prevented was low. This suggests that 
public health efforts that focus on modifying common risk factors will need to address multiple 
risk factors simultaneously to have a substantial impact and that efforts to address key social 
determinants of health must be part of the solution to be maximally effective. 
We are unaware of other studies that have reported the PAF of patient level risk factors for 
severe maternal morbidity, but the risk ratios we reported are comparable to other studies.31,36 
Recently, investigators performed a state-level analysis of factors that contributed to the temporal 
changes in U.S. maternal mortality from 1997-2012.122 Similar to our findings, they reported that 
obesity and low education were important contributors to maternal mortality.  
The findings of our work have important limitations—the first are limitations inherent to 
estimates of PAF and the second are limitations specific to our work.  Estimations of PAF assume 
both causal relationships and exposures with well-defined interventions. Nevertheless, for most of 
these risk factors, we have not defined the intervention that would, for instance, reduce BMI by 
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3.5 units. Lowering BMI could be a result of dietary restriction, exercise, or bariatric surgery (or 
some combination of treatment options), and each may have a different impact on severe maternal 
morbidity risk.132 PAF also assumes that the disease risk is independent across risk factors. 
Altering obesity prevalence, however, likely impacts the prevalence of diabetes and hypertension, 
thereby leading to synergistic effects we have not captured. PAF also does not consider the 
consequences of altering risk factors on the underlying population at risk of severe maternal 
morbidity. For instance, reducing BMI may improve fertility rates, which would increase the 
number of pregnancies and thus increase the number of pregnant women at risk for severe maternal 
morbidity. Finally, our estimates of PAF also assumes all biases are absent.   
Regarding limitations unique to our work, we used a commonly used screening definition 
of severe maternal morbidity, rather than the gold standard of medical chart review.30 If we had 
used the gold standard definition for maternal morbidity recently outlined in a ACOG Obstetric 
Care Consensus, we would expect fewer cases of severe maternal morbidity. However, it is 
difficult to predict the direction and magnitude of potential misclassification without a formal 
quantitative bias analysis.133  Additionally, because we did not perform a medical record review, 
we do not have information about cause-specific morbidity. The PAF of the different risk factors 
we examined may vary by type of morbidity, and this information would be important for health 
systems and public health officials.   
Our work highlights the need to extend research beyond the commonly measured 
individual-level risk factors we examined to include anemia, substance use, pre-pregnancy control 
of pre-existing medical problems and additional social determinants of health. Furthermore, risk 
factors should be expanded to include provider, system, and structural factors, such as state 
Medicaid coverage of pregnancy termination, that contribute to severe maternal morbidity and its 
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subtypes.134 Only with this more holistic understanding of the drivers of severe maternal morbidity 
can we inform care pathways that will powerfully reduce severe maternal morbidity and improve 
maternal health. 
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5.6 Tables and Figures 
Table 11 Characteristics of women delivering newborns at Magee-Womens Hospital in Pittsburgh, PA, 2003-
2012 (N=86,260) 
Characteristic 
Population at risk n (%) 
N=86,260) 
Cases of severe maternal morbidity 
(unadjusted incidence per 100 
delivery hospitalizations) 
Overall 86,260 (100) 1,739 (2.0) 
Maternal prepregnancy BMI 
   Underweight (<18.5kg/m2) 4,102 (4.8) 76 (1.8) 
   Normal weight (18.5-24.9kg/m2) 44,797 (52) 778 (1.7) 
   Overweight (25-29kg/m2) 20,599 (24) 435 (2.1) 
   Obese (≥30kg/m2) 16,772 (20) 450 (2.7) 
Gestational weight gain 
   Below IOM guidelines 14,374 (17) 320 (2.2) 
   Within IOM guidelines 22,282 (26) 383 (1.7) 
   Above IOM guidelines 49,604 (57) 1,036 (2.1) 
Maternal race/ ethnicity 
   Non-Hispanic White 64,681 (75) 1,147 (1.8) 
   Non-Hispanic Black 16,870 (20) 492 (2.9) 
   Other  4,709 (5.5) 100 (2.1) 
Maternal education 
   Less than high school    7,423 (8.6) 226 (3.0) 
   High school 18,810 (22) 461 (2.5) 
   Some college 19,924 (23) 418 (2.1) 
   College graduate 40,103(46) 634 (1.6) 
Maternal age (years) 
   <20    6,009 (7.0) 152 (2.5) 
20-24 15,644 (18) 333 (2.1) 
25-29 23,269 (27) 395 (1.7) 
30-34 25,243 (29) 474 (1.9) 
35-39 13,165 (15) 294 (2.2) 
≥40    3,095 (3.6) 91 (3.0) 
Marital status 
   Unmarried 34,095 (40) 843 (2.5) 
   Married 52,165 (60) 896 (1.7) 
Insurance 
   Private 59,225 (69)  1,028 (1.7) 
   Public/Other 27,035 (31) 711 (2.6) 
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Parity at conception 
   Nulliparous 39,556 (46) 880 (2.2) 
   Multiparous 46,770 (54) 859 (1.8) 
Plurality 
   Singleton 84,328 (98) 1,600 (1.9) 
   Twin 1,932 (2.2) 139 (7.2) 
Preexisting hypertension 
   Yes 2,999 (3.5) 192 (6.4) 
   No        83,261 (97) 1,547 (1.9) 
Preexisting diabetes 
   Yes 1,268 (1.5) 85 (6.7) 
   No        84,992 (99) 1,654 (1.9) 
Smoking during pregnancy 
   Yes 12,555 (15) 276 (2.2) 
   No 73,705 (85) 1,463 (2.0) 
Table 11 Continued
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Table 12 Population attributable fractions for modifiable risk factors of severe maternal morbidity. Magee- Womens Hospital, 2003-2012 (N=86,260) 
Risk factor 
Adjusted risk ratio 
(95% confidence interval) 
Prevalence (n) 
Population attributable 
fraction 
(95% confidence interval)
Total preventable cases 
of severe maternal 
morbidity 
1. Prepregnancy BMI outside normal
range (<18.5 or ≥25kg/m2)
1.1 (1.002, 1.2) 48 (41,590) 6.1 (0.47, 11) 106 
2. Prepregnancy BMI≥25kg/m2 1.1 (1.01, 1.3) 44 (37,564) 6.0 (0.83, 11) 104 
3. ≥35 years of age at delivery 1.5 (1.3, 1.6) 19 (16,260) 7.1 (4.6, 9.4) 123 
4. No college degree 1.2 (1.1, 1.4) 54 (46,160) 13 (5.7, 19) 226 
5. Unmarried 1.01 (0.89, 1.2) 40 (34,094) 1.5 (-4.9, 7.6) 26 
6. Preexisting hypertension 2.4 (2.0, 2.8) 3.5 (2,999) 6.3 (4.8, 7.8) 109 
7. Preexisting diabetes 2.0 (1.5, 2.5) 1.5 (1,268) 2.4 (1.4, 3.4) 41 
8. Smoking during pregnancy 0.92 (0.79, 1.04) 15 (12,554) -1.4 (-3.7, 0.81) -24
9. Gestational weight gain >1 SD 1.3 (1.1, 1.5) 14 (11,754) 4.5 (1.9, 7.1) 78
Term (≥37 weeks) 1.2 (1.0, 1.5) 12 (9,315) 3.0 (0.21, 5.6) 52
Preterm (<37 weeks) 1.3 (1.0, 1.6) 16 (1,752) 4.8 (0.16, 9.2) 83
10. All above risk factors 1.6 (1.1, 2.1)a 93 (80,613)b 36 (14, 53)c 626d 
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6.0 Synthesis 
6.1 Overview of Findings 
The overarching purpose of this dissertation was to advance the understanding of the role 
of weight gain during pregnancy and other known, modifiable risk factors on the risk for severe 
maternal morbidity. 
Specific Aim 1. Determine the association between total gestational weight gain and severe 
maternal morbidity at delivery hospitalization.  
In a retrospective cohort of 84,241 delivery hospitalizations, we investigated whether 
gestational age- and prepregnancy BMI-standardized z-scores were associated with severe 
maternal morbidity at delivery hospitalization. We found that weight gain during pregnancy that 
was in the lower or upper extremes of the distribution was associated with increased risk of severe 
maternal morbidity at delivery hospitalization. When stratified by gestational age at delivery, we 
observed consistently higher absolute risks of severe maternal morbidity among preterm deliveries 
compared with term deliveries across the risk curve. Overall, we found the highest adjusted risk 
difference among those with a z-score of +3 compared with a z-score of 0 (1.6 (0.68, 2.6) per 100 
delivery hospitalizations). We found that the same z-score was associated with the highest risk in 
both, preterm and term deliveries compared with a z-score of 0. Among term deliveries, we found 
that a z-score of +3 was associated with 0.86 (0.09, 1.6) excess cases and among preterm deliveries, 
the same z-score was associated with 3.0 excess cases. The confidence intervals were wider for 
preterm deliveries at this selected z-score, with risk differences ranging from -0.56 excess cases to 
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6.6 excess cases. Even though our confidence intervals overlapped the null among preterm 
deliveries, most compatible risk differences for our data were greater than the null and there was 
a consistent and clear trend of increasing risk among preterm deliveries, which warrants that care 
be taken to avoid extremely low or high weight gain in all groups. Importantly, any weight gain 
higher than the mean was associated with increased risk in both term and preterm deliveries, 
though the magnitude of association in both groups was lower as weight gain was closer to the 
mean. 
Our results agree with the only other known study on the relationship between gestational 
weight gain and risk of severe maternal morbidity. In 2019, Platner, et al. reported that compared 
with weight gain within the 2009 Institute of Medicine recommendations, weight gain above the 
guidelines was associated with a mild increase in odds of severe maternal morbidity or death 
among term deliveries (Adjusted odds ratio (95% confidence interval): 1.08 (1.02, 1.13).92 Those 
who gained ≥20 pounds above the guidelines were at even greater odds compared with those who 
gained within the guidelines (1.21 (1.12, 1.31)). Additionally, this group did not find a notable 
association among those who gained below the IOM recommendations (0.98 (0.92, 1.03). Our 
findings generally agree, but we contribute a very important piece of information to the literature 
in that we add that both, low and high weight gain is associated with increased risk among preterm 
deliveries.  This is crucial because upwards of 40% of cases of severe maternal morbidity are 
among preterm deliveries.32 Preterm delivery in of itself is associated with myriad adverse 
pregnancy outcomes, but our results suggest that optimizing weight gain in this group might be 
beneficial in reducing the risk of the most severe maternal outcomes. Finally, when we explored 
the relationship between gestational weight gain and individual indicators of severe maternal 
morbidity, we found that elevated weight gain was associated with increased risk of ICU 
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admission, prolonged postpartum length of stay, eclampsia, heart failure during procedure, 
puerperal cerebrovascular disorders, and pulmonary edema compared with the mean weight gain 
(Appendix J). We did not stratify these analyses by gestational age at delivery due to sample size 
constraints, but overall, Platner, et. al found similar results among term deliveries, with the risk of 
eclampsia, heart failure, pulmonary edema, blood transfusion, and ventilation all increased among 
those who gained far above the IOM recommendations compared with those within the IOM 
recommendations.92 
Our findings have implications for future research and policy efforts as well as clinical 
practice. An overarching, existing recommendation for which these data likely provide support is 
to avoid very high or low weight gain during pregnancy. Though severe maternal morbidity is a 
set of rare events, along with maternal mortality it is on the highest end of the spectrum of adverse 
maternal outcomes during pregnancy; therefore, it deserves inclusion when considering best 
recommendations if our findings are supported by additional research. Current recommendations 
developed by the Institute of Medicine aimed to balance the risk of various short- and long-term, 
adverse pregnancy outcomes for mother and child.107 And while severe maternal morbidity was 
not an explicit component of the final recommendations, as the specific topic area evolves, future 
committees to develop guidelines will have improved data on which to guide their 
recommendations.  
Recommendations specific to clinicians who care for pregnant women continue to be that 
patients should be counseled on healthy weight gain early and often, being vigilant to recognize 
women at risk of gaining too much weight (i.e. their trajectory is above the recommendations), 
and knowing how and when to intervene. For other researchers, our data confirm existing literature 
and extend our knowledge by showing that the relationship between these factors is apparent in 
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various subgroups of women. The implications for future research efforts will be discussed in later 
sections, however researchers must consider whether to continue with this avenue of research or 
to dedicate resources to other risk factors of interest.  
Specific Aim 2. Determine the association between early gestational weight gain and 
severe maternal morbidity at delivery hospitalization.  
In a retrospective cohort of 4,774 women who had serial, antenatal weight measurements 
at Magee-Womens Hospital, we tested whether weight gain at 16-19 weeks gestation was 
associated with risk of severe maternal morbidity at delivery hospitalization. The overall rate of 
severe maternal morbidity in this sample was 2.1/100 delivery hospitalizations and was highest 
among those in the middle of the distribution of weight gain z-scores and decreased in z-scores 
above and below the mean. After adjusting for confounders, we observed a similar association. 
Compared with a weight gain z-score of 0 (5.2kg at 19 weeks gestation among normal weight 
women), z-scores of -2 and +2 (0.1kg and 13kg at 19 weeks gestation, respectively) were 
associated with -0.80 (-2.3, 0.74) and -1.1 (-2.4, 0.07) excess cases per 100 delivery 
hospitalizations, respectively.  
There are no other studies on the association between weight gain early in pregnancy and 
risk of severe maternal morbidity, and the discordant findings against our total weight gain paper 
were surprising. The most likely driver of the difference in association is selection bias in the early 
weight gain sample, though we cannot explicitly rule out other possibilities, such as our total 
weight gain results being due to reverse causation.  
Our first sensitivity analysis tested the relationship between rate of weight gain in the 
second half of pregnancy and severe maternal morbidity and whether the association helped 
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explain the larger discrepancy with the total weight gain results. We found that the predicted, 
adjusted risk of severe maternal morbidity gradually decreased with increasing weight gain. If 
weight gain in the second half of pregnancy was driving the results of the total weight gain analysis, 
and assuming similar distribution of maternal characteristics in each sample, we would expect a 
positive association between weight gain during the second half of pregnancy and risk of severe 
maternal morbidity at delivery hospitalization. The fact that we saw the opposite lent further 
support that the samples might differ and the early weight gain sample is likely not reflective of 
the general population at risk of severe maternal morbidity. 
We also explored the association between severe maternal morbidity at delivery 
hospitalizations and weight gain at the end of the first trimester and at 24-28 weeks, when 
screening for gestational diabetes typically occurs at Magee. For the former analyses, we found a 
similar risk curve to our findings when we measured weight gain at 16-19 weeks gestation. 
However, the latter analysis resulted in a risk curve more similar to that where we measured weight 
gain during the second half of pregnancy (decreasing risk of severe maternal morbidity with 
increasing weight gain). This shift in relationship, particularly that of z-scores corresponding to 
low weight gain being associated with lower risk to higher risk in the second half of pregnancy, 
suggests that the relationship between weight gain and risk of severe maternal morbidity might not 
be consistent throughout pregnancy. Though we cannot confirm the underlying mechanisms in this 
sample, one possibility is that low weight gain in the second half of pregnancy is indicative of 
underlying health issues that lead to severe adverse events, but low weight gain early in pregnancy 
is not necessarily a marker of nutritional status. 
The final sensitivity analysis, we performed the same analysis as Specific Aim #1 among 
women who had the presence of both, serial weight gain measurements and total weight gain 
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measurements. We would expect a similar relationship if there were no underlying differences in 
the samples from the two specific aims. That we did not might bolster the likelihood that 
differences in results are most likely due to differences in the sample characteristics.  
Overall, though there are other possible drivers of the differences in association, those 
mentioned above have the most evidence. It is possible that the relationship is mediated through 
other factors that lie downstream from early weight gain, but upstream from severe maternal 
morbidity, though these factors are likely to only obscure the direct relationship rather than result 
in a different association. Because we cannot directly compare the results from the first Specific 
Aim, we cannot completely rule out the possibility that weight gain in the second half of pregnancy 
is a more potent risk factor of severe maternal morbidity than weight gain in the first half. 
Typically, women gain the higher proportion of their total weight gain in the second and third 
trimesters, as this is when fetal growth is progressing at the fastest rate.107 For the same reasons, 
we cannot explicitly rule out that our total weight gain results are not due to reverse causality. 
Future research might consider extending this research to examining patterns of gestational weight 
gain, though ideally in populations where both, the overall and case-specific maternal 
characteristics are comparable to the larger body of literature. Third, one’s physiologic state at the 
time of delivery might help explain these disparate results, but again, it is less likely that 
differences in sample characteristics. From a physiologic standpoint, we might have observed a 
positive relationship between total weight gain and risk of severe maternal morbidity because 
increased physical mass may act to increase the risk of delivery complications through both 
challenges for the birth itself to added stress placed on the mother’s body during delivery. 
Interestingly, among women in this sample who had both, early and total weight gain 
measurements, 72% remained in the same z-score category (<-1 SD, -1 to +1 SD, or >+1 SD) 
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between measurements (72% among noncases and 78% among cases). Though the majority follow 
the expected pattern, future research to examine weight gain trajectory might elucidate the 
relationship further. 
Overall, additional research must be conducted in larger samples so that our results can be 
confirmed/ refuted as well as extended by examining specific indicators of severe maternal 
morbidity. The women for whom serial weight gain measurements are available might not be 
representative of the larger population. These data are not regularly or consistently entered across 
facilities (e.g. outpatient obstetrician offices that regularly use electronic medical records versus 
those that do not). It is plausible and likely that those facilities who regularly use and upload serial 
weight measurements so that they are available to researchers serve different patient populations 
than those who do not. This would substantively impact our results, though without further 
exploration at the facility level to determine the clinical characteristics of the women being treated, 
we cannot predict the direction and magnitude that it would change the association between early 
weight gain and risk of severe maternal morbidity. These limitations also impair our ability to 
compare our total weight gain results with these results. Future research with these data should 
explore and account for potential sampling variation between facilities. 
Specific Aim 3. Determine the population attributable fraction of modifiable risk factors 
of severe maternal morbidity (maternal education, marital status, prepregnancy BMI, preexisting 
hypertension or diabetes, advanced maternal age at delivery, smoking during pregnancy, and 
gestational weight gain). 
In a sample of 86,260 delivery hospitalizations at Magee-Womens Hospital, we calculated 
the percent of the severe maternal morbidity that could be prevented if 8, known, modifiable risk 
84 
factors were reduced to optimal levels. We found that by concurrently reducing all these risk 
factors to optimal levels, 36% of the severe maternal morbidity in this sample could be prevented. 
Eliminated or reducing individual risk factors had more modest reductions. The risk factors that 
conferred the most risk to severe maternal morbidity were lacking a college degree (13%), 
advanced maternal age (7.1%), preexisting hypertension (6.3%), prepregnancy overweight/ 
obesity (6.0%), and gestational weight gain >1 SD above the mean (4.5%). 
Though preventing roughly 1 in 10-20 cases of severe maternal morbidity by targeting a 
single risk factor is significant, most of these calculations assume that the risk factor is eliminated 
entirely from the sample (e.g. no one is overweight or obese), which is not tenable. Therefore, real-
world reductions in cases would presumably be lower. For example, published interventions to 
reduce BMI have varying levels of success and magnitudes of weight loss. Bariatric surgery is 
effective at reducing BMI among severely obese women (roughly 15% of total weight lost),135 but 
is also expensive, time-consuming, and requires strict adherence by the patient. Non-surgical 
weight loss interventions are less intensive, but require consistent buy-in from participants and 
when effective, result in less weight loss (roughly 5%).129  Furthermore, there is insufficient 
evidence regarding pregnancy outcomes among women who have undergone bariatric surgery and 
subsequently became pregnant.  
Other factors that we studied would require structural changes at the population level. We 
found that lack of college education was associated with the highest population attributable 
fraction in this sample. As discussed, this finding was not entirely surprising, as in 2013 the 
Institute of Medicine highlighted societal factors as major contributors to health disadvantage.131 
However, education level is correlated with other factors associated with adverse pregnancy 
outcomes and overall health, including other risk factors of severe maternal morbidity examined 
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here. Though intervening on population-level risk factors like education is not a short-term 
solution, its impact would likely be significant and long-lasting because of the downstream effects 
it has on other elements of health. 
More short-term goals should include better understanding the interplay between risk 
factors and recognize that any primary preventive efforts need multidisciplinary approaches to 
improve the health profile of those at increased risk. Our results lend support to the notion that less 
than half of severe maternal morbidities are preventable.13,22,23,136 An additional layer is the 
evidence that among preventable cases, most are due to provider and system factors112 rather than 
individual patient factors. More research is needed to explore these individual factors in large and 
diverse samples, but our early findings suggest that these investigations need to continue. 
6.2 Strengths and Limitations 
This study has several strengths that add value to the existing literature. First, using 
prepregnancy BMI and gestational age-specific z-scores to define weight gain allows us to 
remove potential confounding by gestational age137 and, importantly, include preterm deliveries 
in our sample. Second, we addressed missing data using rigorous methodology, performed 
complete case analyses and sensitivity analyses where we modified our definition of severe 
maternal morbidity. Third, we used a large, single institution dataset that linked hospital 
discharge, birth certificate, and clinical data to include ICU admission and prolonged postpartum 
length of stay as part of our outcome definition, which are commonly used as indicators of 
severe maternal morbidity.30 
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There are some overarching limitations that must be considered when interpreting our 
results. First, as mentioned, our definition of severe maternal morbidity is not based on a gold 
standard of chart review, but rather a reasonable, externally-validated definition that has been used 
in previous research.30 Even so, it is likely that we overestimated the true incidence of severe 
maternal morbidity, particularly those morbidities considered sentinel events. Perhaps the largest 
contributor to this possible misclassification is the using of binary variable for blood transfusion, 
regardless of volume given, as a positive indicator of severe maternal morbidity. Current ACOG 
recommendations state that blood transfusions consisting of less than 4 units might not constitute 
a true morbidity.21 However, it is important to consider that any amount of blood given during 
delivery could be considered a severe event by some women and their families.30 Regardless, if 
there was differential misclassification of our outcome by gestational weight gain, it is possible 
that our results are biased. Specifically, if in the lower and upper ranges of weight gain the 
incidence of severe maternal morbidity was overestimated compared with weight gain closer to 
the mean weight gain, we would expect our results to be biased away from the null. However, 
without additional data of the direction and magnitude of the bias as well as a format bias analyses, 
it is not possible to determine with complete certainty whether there was any impact on our results. 
But, we performed a series of sensitivity analyses where we modified our definition of severe 
maternal morbidity and found no significant changes. Severe maternal morbidity is a 
heterogeneous and, outside sentinel events, a somewhat subjective outcome. Even when gold 
standards are created in the literature, the definition is dependent on the clinicians’ and researchers’ 
opinion of what truly constitutes one of these outcomes.17,19,30 For example, Main et al. found that 
only 491 of 1,313 screen positive cases were true severe morbidities,30 Geller et al. reported 186 
of 339 screen positive cases were true severe morbidities,14 and You, et al. 167 of 815 were true 
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positives.19 Importantly, however, is that each one of these studies used a different methodology 
for screening and review (e.g. Main, et al. used a gold standard of conditions agreed upon by 10 
obstetric researchers, Geller, et al. used a physician-narrated summary and then used qualitative 
discussions to review screen positive cases, and You, et al. used a research assistant to provide a 
narrative of each case to three physicians, who by majority rule, determined the validity of each 
case). While we as researchers intrinsically trust the judgement of experts, there will always be a 
subjective component to this area of research so long as there is disagreement in what constitutes 
a near miss. 
Though it is most likely that we overestimated the true incidence in this sample, there is 
also the possibility of false negatives when using administrative datasets without review of screen 
negative and screen positive observations. Appearing in even some of the most cited literature, it 
is often not feasible to review screen negative cases because of the low incidence of severe 
maternal morbidity and the number of observations needed to perform an analysis with adequate 
statistical power. Truly rigorous research efforts would review all screen positive and screen 
negative cases to calculate the actual sensitivity, specificity, and negative predictive value of a 
definition. Unfortunately, we know of no research that has undertaken the task and we therefore 
must rely on positive predictive value as the only measure of validity. We cannot comment on the 
potential false negative rate of identifying severe maternal morbidity, but false positives vary 
widely between studies, depending on both the method of data ascertainment and the gold standard 
used to validate the screening criteria. Future epidemiologic research should seek to determine 
reasonable false positive and false negative rates and incorporate bias analyses to determine the 
impact of outcome misclassification on effect estimates. 
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A second, broad category of limitations to this work is related to our exposure definitions, 
specifically those related to weight gain. The highest leverage factor that would impact our 
exposure ascertainment is the fact that prepregnancy weight was self-reported. If misreported, 
both, prepregnancy BMI and gestational weight gain would be skewed; if prepregnancy weight is 
underestimated (the most likely scenario), prepregnancy BMI would be underestimated and 
gestational weight gain measures would be inflated which would potentially bias our results away 
from the null. However, without a formal bias analysis regarding the direction and magnitude of 
any misclassification, we cannot confirm its impact on our results. Finally, while we believe that 
utilizing gestational weight gain z-scores is the most rigorous method of accounting for potential 
confounding by gestational age for exposure/ outcome relationships related to preterm birth, there 
are others that argue that this method might not mitigate confounding bias in these scenarios.138 
The authors’ primary concern is that the creation of z-score charts might not translate from one 
sample or population to the next. Though future research should compare methods across 
populations, in our analyses, we used the sample population in which the z-score charts were 
originally created so there is no reason to suspect these methods inappropriate. 
Missing data can also lead to spurious results if not addressed properly. In our total weight 
gain and population attributable fraction papers (Specific Aims #1 and #2), the variables with the 
highest percent missing were prepregnancy weight or height (24%) and delivery weight (8.5%). 
We implemented multiple imputation using chained equations (MICE) for both analyses to address 
missing data. This was an optimal strategy because, unlike other methods using multiple 
imputation (i.e. MVN), we could specify unique distributions for each variable (e.g. continuous, 
binary, etc.) rather than being limited and having to transform variables to achieve a consistent 
distribution.139 While more laborious and higher potential for misspecification, the resulting 
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imputed datasets are likely a better representation of the data. Furthermore, using multiple 
imputation as a strategy has been shown to be effective in imputing variables with up to 50% 
missing data.140 We confirmed that our data were not missing completely at random, but there 
were no concerning patterns within our key variables that would lead us to believe imputation was 
not appropriate (i.e. missing at random). However, if we had violated this assumption and our data 
were not missing at random then our results might be spurious. In Specific Aim #1, where we 
examined early gestational weight gain and risk of severe maternal morbidity, we chose to limit 
our analysis to only those with complete data because we determined the added complexity of 
imputing data in so few individuals and the potential for misspecification did not add rigor to the 
overall methodology.  
Finally, our findings must be applied with caution in facilities whose patient population 
differs from Magee. Magee is a high-volume delivery center (9,000 deliveries per year) and is 
responsible for many of the high-risk deliveries in Allegheny County. We would expect the 
incidence of severe maternal morbidity to be higher than the national average because more high-
risk pregnancies culminate at Magee. Also, though Magee serves a diverse racial, ethnic, 
geographic, and socioeconomic population, its composition is different from other samples. For 
example, studies from California have a larger proportion of Hispanic women and a lower 
proportion of non-Hispanic Black women compared with our sample.30 These differences must be 
recognized given the racial disparities in the incidence of severe maternal morbidity. As previous 
research has shown a high contribution of system and provider factors accounting for the incidence 
of severe maternal morbidity, these differences between Magee and other facilities must be 
considered. Our results might not be applicable to more rural healthcare centers or those that do 
not have clinical specialists trained in managing high-risk pregnancies and deliveries. Importantly, 
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the results from Specific Aim #2 should not be applied to the general population of those at risk 
of severe maternal morbidity because the underlying patient characteristics likely differ from those 
of other large, population-based cohorts and the facilities from which serial weight gain data are 
available are likely not representative of the larger patient population. The sample used in Specific 
Aim #1 follows published cohorts more closely and might have more relevance to the broader, at 
risk population. 
6.3 Public Health Significance 
The importance of understanding how to better prevent severe maternal morbidity and 
mortality cannot be overstated. The United States has, by many measures, the worst maternal 
health among high-income15% countries112 and even with the vast technological and intellectual 
resources available, the record does not appear to be improving a great deal.1,141 There are also 
profound and persistent racial, ethnic, and socioeconomic disparities in the incidence of severe 
maternal morbidity.39,130,142 Non-Hispanic Black women are over 60% more likely to face severe 
maternal morbidity in this sample than non-Hispanic White women, with others reporting similar 
or greater inequities.39 We took a practical, epidemiologic approach and directed our focus on 
known, modifiable risk factors of severe maternal morbidity and applied rigorous methodologies 
to quantify the burden they place on the incidence of this outcome. 
Training our analyses on modifiable risk factors, and particularly including those amenable 
to intervention during pregnancy, was crucial because most of the available literature has either 
taken a broad approach (i.e. including many risk factors)29,35,36 or focused on risk factors that are 
not modifiable during pregnancy (e.g. prepregnancy body mass index)89. As discussed, half of all 
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pregnancies are unplanned and many do not or cannot seek preconception care,5,6 so modifying 
risk factors such as body mass index often isn’t feasible. We focused on modifiable risk factors 
because our intent is to contribute to research efforts whose ultimate goal is to informing risk 
identification and the development of sustainable intervention strategies. 
This dissertation adds support that avoiding very suboptimal or excessive weight gain 
might be beneficial in reducing one’s risk for adverse pregnancy outcomes.107 Once prenatal care 
is initiated, patients must be educated about healthy weight gain during pregnancy. Sadly, while 
most clinicians report sharing this information, current literature suggests that potentially only half 
of pregnancy women report receiving weight gain advice.143 Furthermore, in this same prospective 
cohort study of nearly 1,500 women, current advice had limited effect on preventing inadequate 
or excessive weight gain during pregnancy according to the current Institute of Medicine 
guidelines. Furthermore, among some populations, patients report being given inconsistent advice 
or advice that is outside the current guidelines,144,145 which might place women at higher risk of 
gaining outside the recommendations. Though outside the scope of this research, these data, in 
conjunction with rising morbidity and mortality rates and the suggestion that most preventable 
cases of morbidity are due to system and provider factors,18 suggest a troubling pattern between 
proper healthcare being provided throughout pregnancy and delivery with adverse maternal 
outcomes.   
Adding to our findings on early and total weight gain as risk factors for severe maternal 
morbidity, we found that by optimizing any one of the eight, modifiable risk factors individually, 
only modest reductions in the incidence of severe maternal morbidity could be expected. As 
discussed, most of these calculations assumed that the risk factor was eliminated, which is 
unrealistic in practice, so real-world reductions would be much lower. Even if all the risk factors 
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we examined were concurrently reduced to optimal levels, less than 40% of the total cases of 
severe maternal morbidity in this sample could be prevented. Others have suggested that upwards 
of 50% of the burden of severe maternal morbidity is not preventable; as our estimates do not 
account for the other 50%, there appears to be space for prevention (14% of the burden if the 
estimates from other studies are consistent in our sample). 
Assuming we did not exclude a patient-level risk factor that had high leverage on our 
outcome, we can posit that, echoing previous research, more than half of the cases of severe 
maternal morbidity are either 1) not due to patient-level risk factors and/or 2) not preventable. 
With either possibility, our focus must widen to include provider and system-level factors to gain 
a more holistic understanding of the preventable burden of severe maternal morbidity. Not all 
severe maternal morbidities are preventable and can be due to individual, provider, or system-level 
factors. This dissertation focused solely on determining the associations between individual level 
risk factors and risk of severe maternal morbidity during delivery hospitalization. 
Another important finding of our work is that the association between high and low 
gestational weight gain and severe maternal morbidity is present among term and preterm births 
and that the absolute risk is consistently higher among preterm births across all z-scores. However, 
we found no evidence of effect measure modification by gestational age at delivery that would 
suggest that there are differences in risk between various weight gain z-scores that vary between 
term and preterm births. Approximately 10% of all births in the U.S. are preterm and nearly 40% 
of severe maternal morbidity cases are among women who deliver preterm.32 So, our observations 
here support previous recommendations that optimizing weight gain during pregnancy is important 
for all women.146  
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Our immediate attention was on relatively short-term solutions, but we alluded to the 
importance of larger, sustainable, policy and population-level change. Improving education for 
clinicians to recognize and manage high risk patients, both during pregnancy and at delivery is an 
important first step for future research and clinical efforts. In fact, efforts such as the Alliance for 
Innovation on Maternal Health (AIM), have been designed for this purpose147; a way to educate 
states, hospitals, birthing centers, and maternity care providers on the best practices for maternal 
care developed by “national multidisciplinary organizations”. While these efforts are promising, 
there are limited data regarding its impact. Without systematic change in how we make affordable 
healthcare available to all women and improve on the profound disparities that exist, it is unlikely 
that the upward trend in adverse maternal outcomes during pregnancy will abate.  
6.4 Future Research 
As recognized by medical and professional societies, having standardized definitions of 
severe maternal morbidity across all states and facilities is unlikely feasible due to differences in 
data collection, recording, and reviewing. However, future research in the U.S. should focus on 
developing the surveillance and reporting tools needed to expand our window of outcome 
ascertainment. Limiting severe events that happen during delivery hospitalizations is likely leading 
to underestimation of the true burden of severe maternal morbidity. It is not uncommon for women 
to have a severe maternal morbidity or even face death after hospital discharge. In fact, the World 
Health Organization definition of severe maternal morbidity includes events up through 42 days 
postpartum.11 Including these cases in future epidemiologic research and clinical case reviews is 
critical for identifying preventable cases. In a related call to action, a 2019 clinical opinion in the 
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American Journal of Obstetrics and Gynecology argued that a state-by-state maternal mortality 
review to be established.148 Though such an undertaking for reviewing all cases of severe maternal 
morbidity would not be feasible, better understanding of the causes leading up to mortality would 
help prevent severe maternal morbidity, as well. 
Also related to our outcome, future epidemiologic research should be designed to study 
individual indicators of severe maternal morbidity. Understanding severe maternal morbidity as a 
composite measure is useful for broad risk identification strategies, but we are unable to determine 
the underlying causal mechanisms since the phenotypes of severe maternal morbidity are varied 
and unique. 
Second, our findings on the relationship between early and total gestational weight gain 
and risk of severe maternal morbidity point to possible follow up studies and provides additional 
information for weighing research priorities. Studies should examine these relationships according 
to specific indicators of severe maternal morbidity and might consider the pattern and trajectory 
of weight gain as an exposure of interest. Overall, although we found larger effect sizes for other 
risk factors, gestational weight gain remains one of the only risk factors amenable to intervention 
during pregnancy. Adding these recommendations to future research could, in the future, 
potentially help identify subgroups that would benefit most from surveillance and intervention. 
Third, longer-term cohorts should be established to better understand the lasting effects 
that severe maternal morbidity has on patients, their families, and the healthcare systems they 
utilize. Along with the immediate impact of severe maternal morbidity, including medical 
implications and cost to both patient and facility, there are potential lasting effects that have been 
examined by too few, particularly in the U.S.149 In developing these efforts, researchers should 
include patient and stakeholder input during all phases of work. The Patient Centered Outcomes 
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Research Initiative (PCORI) has placed focus on this type of work in several areas, including 
pregnancy research.150 Including stakeholders outside clinical and research staff in the discussion 
of severe maternal morbidity research would help add context and focus research in new directions. 
As one example, there is disagreement throughout the literature regarding what constitutes severe 
maternal morbidity, but nearly all discussion is through a physician or researcher’s lens; patients 
and their families bear the lasting burden of facing one of these events and would have valuable 
insight as the field progresses.   
Fourth, while epidemiologic research of individual-level risk factors is important and, as 
discussed, should be part of any risk reduction strategy, future efforts must expand their focus to 
facility-level and policy-level risk factors. As our data suggest and previous work has shown, 
upwards of half of preventable cases are due to provider- and system-level factors.18,136 By using 
similar methods as we have shown here (e.g. quantifying the risk that certain factors confer on 
severe maternal morbidity by calculating the population attributable fraction), this work can and 
should be done at individual institutions.  
Overall, there must be a research environment that focuses on multidisciplinary 
collaboration between researchers, clinicians, and stakeholders. Research must aim to develop and 
test sustainable strategies that can lead to quantifiable reductions in the incidence of severe 
maternal morbidity. 
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Appendix A Sample Selection 
Appendix Figure 1 Specific Aim #1 sample selection 
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Appendix Figure 2 Specific Aim #2 sample selection 
Appendix Figure 3 Specific Aim #3 sample selection 
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Appendix B Defining severe maternal morbidity and its distribution by indicator and 
Specific Aim 
Appendix Table 1 Severe maternal morbidity indicators and corresponding ICD-9 codes 
Severe Maternal Morbidity Indicator ICD-9-CM Codes 
1. Acute myocardial infarction 410.xx
2. Acute renal failure 584.x, 669.3x
3. Adult respiratory distress syndrome 518.5, 518.81,518.82, 518.84, 799.1
4. Amniotic fluid embolism 673.1x
5. Aneurysm 441.xx
6. Cardiac arrest/ ventricular fibrillation 427.41, 427.42, 427.5
7. Disseminated intravascular
coagulation
286.6, 286.9, 666.3x 
8. Eclampsia 642.6x 
9. Heart failure during procedure or
surgery
669.4x, 997.1 
10. Puerperal cerebrovascular disorders 430, 431, 432.x, 433.xx, 434.xx, 436, 
437.x, 671.5x, 674.0x, 997.2, 999.2
11. Pulmonary edema 428.1, 518.4
12. Severe anesthesia complications 668.0x, 668.1, 668.2x
13. Sepsis 038.xx, 995.91, 995.92
14. Shock 669.1x, 785.5x, 995.0, 995.4, 998.0
15. Sickle cell anemia with crisis 282.62, 282.64, 282.69
16. Thrombotic embolism 415.1x, 673.0x, 673.2x, 673.3x, 673.8x
17. Blood transfusion 99.0x
18. Conversion of cardiac rhythm 99.6x
19. Hysterectomy 68.3x-68.9
20. Temporary tracheostomy 31.1
21. Ventilation 93.90, 96.01-96.05, 96.7x
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Appendix Figure 4 Specific Aim #1 composition of severe maternal morbidity by indicator 
Appendix Figure 5 Specific Aim #2 composition of severe maternal morbidity by indicator 
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Appendix Figure 6 Specific Aim #3 composition of severe maternal morbidity by indicator 
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Appendix Table 2 Severe maternal morbidity indicators by Specific Aim 
Severe maternal morbidity 
indicator 
Specific Aim #1 
(n=84,241) 
Specific Aim #2 
(n=4,774) 
Specific Aim #3 
cohort (n=86,260) 
Cases 
(n) 
% Cases 
(n) 
% Cases 
(n) 
% 
Intensive care unit admission 474 30 32 33 516 30 
Prolonged postpartum length 
of stay 
404 25 26 26 441 25 
Acute myocardial infarction 1 0.06 0 0 1 0.06 
Acute renal failure 81 5.1 5 5.2 89 5.1 
Adult respiratory distress 
syndrome 
89 5.6 6 6.3 94 5.4 
Amniotic fluid embolism 7 0.44 1 1.0 7 0.40 
Aneurysm 2 0.13 0 0 2 0.11 
Cardiac arrest/ ventricular 
fibrillation 
9 0.56 2 2.1 9 0.52 
Disseminated intravascular 
coagulation 
100 6.3 8 8.3 112 6.4 
Eclampsia 67 4.2 8 8.3 74 4.3 
Heart failure during 
procedure or surgery 
431 27 21 22 471 27 
Puerperal cerebrovascular 
disorders 
28 1.8 5 5.2 31 1.8 
Pulmonary edema 39 2.4 0 0 43 2.5 
Severe anesthesia 
complications 
25 1.6 4 4.2 25 1.4 
Sepsis 41 2.6 1 1.0 43 2.5 
Shock 57 3.5 4 4.2 59 3.4 
Sickle cell anemia with crisis 10 0.63 0 0 11 0.63 
Thrombotic embolism 17 1.1 3 3.1 19 1.1 
Blood transfusion 469 29 27 28 525 30 
Conversion of cardiac 
rhythm 
1 0.06 0 0 1 0.06 
Hysterectomy 93 5.8 4 4.2 103 5.9 
Temporary tracheostomy 2 0.13 0 0 2 0.11 
Ventilation 42 2.6 1 1.0 49 2.8 
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Appendix C Selection of confounders using directed acyclic graphs 
Appendix Figure 7 Confounders of the relationship between gestational weight gain and severe maternal 
morbidity 
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Appendix D 2009 Institute of Medicine weight gain recommendations 
Appendix Table 3 Institute of Medicine weight gain guidelines and corresponding z-scores 
Prepregnancy BMI 
Total 
weight gain 
(kg) 
Corresponding z-
scores at 40 
weeks gestation 
Rates of weight 
gain 2nd and 3rd 
trimesters 
(kg/week)* 
Corresponding 
z-scores at 19
weeks
gestation
Underweight 
(<18.5kg/m2) 
12.5 to 18 -0.55 to 0.48 0.44 to 0.58 0.01 to 0.35 
Normal weight  
(18.5-24.9 kg/m2) 
11.5 to 16 -0.95 to -0.07 0.35 to 0.50 -0.26 to 0.08
Overweight 
 (25-29.9kg/m2) 
7 to 11.5 -1.33 to -0.6 0.23 to 0.33 -0.27 to -0.12
Obese 1 
(30-34.9kg/m2) 
5 to 9 -1.1 to -0.5 0.17 to 0.27 -0.55 to 0.08
Obese 2 
(35-39.9kg/m2) 
5 to 9 -0.6 to -0.1 0.17 to 0.27 0.23 to 0.35 
Obese 3 
(≥40kg/m2) 
5 to 9 -0.17 to 0.18 0.17 to 0.27 0.40 to 0.49 
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Appendix E Sensitivity analyses for Specific Aim #1 
Appendix Table 4 Characteristics of women delivering singleton infants at Magee-Womens Hospital, 2003-
2012 (N=84,241) 
Maternal characteristic 
n(% of cohort) 
Term Preterm 
Overall 74,879 (89) 9,362 (11) 
Prepregnancy body mass index (BMI cutpoints) 
   Underweight 
   (<18.5kg/m2) 
3,529 (4.7) 567 (6.1) 
   Normal weight  
   (18.5-24.9kg/m2) 
39,357 (53) 4,352 (46) 
   Overweight (25.0-29.9kg/m2) 17,860 (24) 2,239 (24) 
   Obese (≥30.0kg/m2) 14,133 (19) 2,204 (24) 
Age (years) 
   <20 5,080 (6.8) 850 (9.1) 
20-30 33,622 (45) 4,464 (48) 
>30 36,177 (48) 4,048 (43) 
Race/ ethnicity 
   Non-Hispanic White 56,408 (75) 6,654 (71) 
   Non-Hispanic Black 14,218 (19) 2,322 (25) 
   Other  4,253 (5.7) 386 (4.1) 
Parity at conception 
   0 34,213 (46) 44,385 (47) 
   1 or more 40,666 (54) 54,977 (53) 
Marital status 
   Unmarried 28,579 (38) 4,871 (48) 
   Married 46,300 (62) 4,491 (52) 
Education 
   High school or less 21,810 (29) 3,884 (42) 
   Some college 17,069 (23) 2,408 (26) 
   College graduate 36,000 (48) 3,070 (33) 
Preexisting hypertension or 
diabetes 
   Yes 2,581 (3.4) 1,162 (12) 
   No 72,298 (97) 8,200 (88) 
Smoking during pregnancy 
   Yes 10,272 (14) 2,051 (22) 
   No 64,607 (86) 7,311 (78) 
Insurance 
   Private 39,516 (53) 4,095 (44) 
   Public/ Other 35,363 (47) 5,267 (56) 
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Appendix Table 5 Mean z-score among singleton pregnancies at delivery by maternal characteristic and 
gestational age at delivery. Magee-Womens Hospital, 2003-2012 (N=84,241) 
Characteristic 
Mean (SD) z-score at delivery 
Term Preterm 
Prepregnancy body mass index 
(BMI cutpoints) 
   Underweight (<18.5kg/m2) 0.10 (0.99) 0.06 (1.10 
   Normal weight (18.5-24.9kg/m2) -0.13 (1.1) -0.25 (1.3)
   Overweight (25.0-29.9kg/m2) -0.14 (1.0) -0.14 (1.2)
   Obese (≥30.0kg/m2) 0.02 (1.0) 0.10 (1.2)
Maternal age (years) 
   <20 -0.03 (1.1) -0.18 (1.4)
20-30 -0.05 (1.1) -0.10 (1.3)
>30 -0.14 (1.0) -0.14 (1.2)
Maternal race/ ethnicity 
   Non-Hispanic White -0.06 (1.0) -0.08 (1.2)
   Non-Hispanic Black -0.14 (1.2) -0.21 (1.4)
   Other  -0.37 (1.0) -0.31 (1.2)
Parity at conception 
   0 0.01 (1.0) 0.02 (1.2) 
   1 or more -0.18 (1.1) -0.25 (1.3)
Marital status 
   Unmarried -0.06 (1.1) -0.16 (1.3)
   Married -0.12 (0.99) -0.08 (1.2)
Maternal education 
   High school or less -0.10 (1.2) -0.21 (1.3)
   Some college -0.05 (1.0) -0.05 (1.3)
   College graduate -0.11 (0.97) -0.08 (1.2)
Preexisting hypertension or diabetes 
   Yes 0.06 (1.2) 0.16 (1.3) 
   No -0.10 (1.0) -0.16 (1.3)
Smoking during pregnancy 
   Yes -0.17 (1.2) -0.31 (1.3)
   No -0.08 (1.0) -0.07 (1.2)
Insurance 
   Private -0.08 (0.99) -0.07 1.2)
   Public/ Other -0.10 (1.1) -0.16 (1.3)
a <11kg among normal weight, 9.5kg among overweight, and 3.3kg among obese women at 
 40 weeks’ gestation.  
b 11-23kg among normal weight, 9.5-25kg among overweight, and 3.3-19kg among obese 
c >23kg among normal weight, >25kg among overweight, and >19kg among obese women. 
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Appendix Table 6 Incidence of severe maternal morbidity by maternal characteristic. Magee-Womens 
Hospital, 2003-2012 (N=84,241) 
Maternal characteristic 
Cases of severe maternal morbidity 
(unadjusted incidence) 
Term Preterm 
Overall 997 (1.3) 600 (6.4) 
Prepregnancy body mass index 
(BMI cutpoints) 
   Underweight (<18.5kg/m2) 44 (1.3) 24 (4.3) 
   Normal weight (18.5-24.9kg/m2) 469 (1.2) 231 (5.3) 
   Overweight (25.0-29.9kg/m2) 245 (1.4) 155 (7.0) 
   Obese (≥30.0kg/m2) 124 (1.7) 99 (8.5) 
Maternal age (years) 
   <20 93 (1.8) 53 (6.2) 
20-30  427 (1.3) 242 (5.4) 
>30  477 (1.3) 305 (7.5) 
Maternal race/ ethnicity 
   Non-Hispanic White 629 (1.1) 404 (6.1) 
   Non-Hispanic Black 292 (2.1) 176 (7.6) 
   Other  76 (1.8) 19 (5.0) 
Parity at conception 
   0 538 (1.6) 255 (5.8) 
   1 or more 459 (1.1) 344 (6.9) 
Marital status 
   Unmarried 471 (1.7) 325 (6.7) 
   Married 526 (1.1) 274 (6.1) 
Maternal education 
   High school or less 372 (1.7) 265 (6.8) 
   Some college 223 (1.3) 167 (7.0) 
   College graduate 402 (1.1) 167 (5.4) 
Preexisting hypertension or diabetes 
   Yes 74 (2.9) 147 (13) 
   No 924 (1.3) 452 (5.5) 
Smoking during pregnancy 
   Yes 147 (1.4) 112 (5.5) 
   No 851 (1.3) 487 (6.7) 
Insurance 
   Private 448 (1.1) 250 (6.1) 
   Public/ Other 549 (1.6) 349 (6.6) 
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Appendix Figure 8 Adjusted, predicted risk of severe maternal morbidity by gestational age at delivery and 
weight gain z-score. 
Note: For both curves, the solid line represents point estimates, dashed lines represent 95% 
confidence intervals. Adjusted for maternal age, prepregnancy BMI, maternal race, maternal 
education, smoking during pregnancy, marital status, parity, preexisting hypertension or diabetes, 
and primary method of payment. Pittsburgh, PA. N=84,241 
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Appendix Table 7 Cumulative incidence of severe maternal morbidity among term deliveries by gestational weight gain z-score category. Magee-
Womens Hospital 2003-2012 (N=74,879) 
Gestational 
weight gain 
z-score category
n at risk Unadjusted risk (cases) 
Unadjusted RD 
(95% CI) 
Adjusted RD 
(95% CI) 
<-2 2,745 1.5 (39) 0.26 (-0.26, 0.78) 0.12 (-0.37, 0.61) 
-2 to <-1 8,894 1.3 (119) 0.09 (-0.20, 0.38) 0.04 (-0.25, 0.33) 
-1 to <0 27,373 1.2 (329) Reference Reference 
0 to <+1 26,768 1.3 (350) 0.13 (-0.09, 0.34) 0.08 (-0.14, 0.30) 
+1 to <+2 8,063 1.6 (131) 0.37 (0.02, 0.73) 0.26 (-0.08, 0.61) 
≥+2 1,036 2.7 (29) 1.5 (0.41, 2.5) 1.3 (0.28, 2.2) 
40-week gestation equivalent weight gain for normal weight women: -2SD(7.0kg);
-1SD(11kg); 0SD(16kg); 1SD(23kg); 2SD(31kg)
Appendix Table 8 Cumulative incidence of severe maternal morbidity among preterm deliveries by gestational weight gain z-score category. Magee-
Womens Hospital 2003-2012 (N=9,362) 
Gestational 
weight gain 
z-score category
n at risk Unadjusted risk (cases) 
Unadjusted RD 
(95% CI) 
Adjusted RD 
(95% CI) 
<-2 611 7.1 (47) 1.2 (-1.4, 3.9) 1.1 (-1.6, 3.8) 
-2 to <-1 1,267 5.3 (66) -0.61 (-2.5, 1.2) -0.58 (-2.5, 1.3)
-1 to <0 2,925 5.9 (171) Reference Reference
0 to <+1 3,015 6.5 (192) 0.61 (-0.80, 2.0) 0.28 (-1.1, 1.7)
+1 to <+2 1,300 7.6 (103) 1.7 (-0.25, 3.6) 1.1 (-0.82, 3.0)
≥+2 244 9.3 (21) 3.4 (-1.1, 7.9) 2.7 (-1.6, 7.0)
40-week gestation equivalent weight gain for normal weight women: -2SD(7.0kg);
-1SD(11kg); 0SD(16kg); 1SD(23kg); 2SD(31kg)
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Appendix Table 9 Estimated number of excess cases of severe maternal morbidity per 100 delivery 
hospitalizations by select gestational weight gain z-scores. Term delivery hospitalizations at Magee-Womens 
Hospital 2003-2012 (N=74,879) 
Gestational weight 
gain z-score category 
Adjusted risk per 100 delivery 
hospitalizations 
(95% confidence interval) 
Adjusted RD per 100 delivery 
hospitalizations 
(95% confidence interval) 
-3 SD 1.3 (0.97, 1.6) 0.01 (-0.35, 0.36) 
-2.5 SD 1.3 (1.0, 1.5) -0.01 (-0.29, 0.28)
-2 SD 1.3 (1.1, 1.5) -0.02 (-0.24, 0.20)
-1.5 SD 1.3 (1.1, 1.4) -0.03 (-0.18, 0.12)
-1 SD 1.2 (1.1, 1.3) -0.04 (-0.13, 0.04)
-0.5 SD 1.2 (1.1, 1.3) -0.04 (-0.08, 0.00001)
0 1.3 (1.2, 1.4) Reference 
+0.5 SD 1.2 (1.0, 1.4) 0.09 (0.03, 0.15) 
+1 SD 1.5 (1.3, 1.6) 0.22 (0.05, 0.38) 
+1.5 SD 1.6 (1.4, 1.9) 0.37 (0.08, 0.66) 
+2 SD 1.7 (1.4, 2.0) 0.53 (0.09, 0.96) 
+2.5 SD 2.0 (1.4, 2.6) 0.70 (0.09, 1.3) 
+3 SD 2.1 (1.4, 2.9) 0.86 (0.09, 1.6) 
40-week gestation equivalent weight gain for normal weight women: -2SD(7.0kg);
-1SD(11kg); 0SD(16kg); 1SD(23kg); 2SD(31kg)
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Appendix Table 10 Estimated number of excess cases of severe maternal morbidity per 100 delivery 
hospitalizations by select gestational weight gain z-scores. Preterm delivery hospitalizations at Magee-
Womens Hospital 2003-2012 (N=9,362) 
Gestational weight 
gain z-score category 
Adjusted risk per 100 delivery 
hospitalizations 
(95% confidence interval) 
Adjusted RD per 100 delivery 
hospitalizations 
(95% confidence interval) 
-3 SD 6.6 (4.9, 8.2) 0.44 (-1.4, 2.2) 
-2.5 SD 6.4 (5.1, 7.7) 0.31 (-1.1, 1.7) 
-2 SD 6.3 (5.3, 7.3) -0.18 (-0.90, 1.3)
-1.5 SD 6.2 (5.4, 6.9) 0.05 (-0.69, 0.79)
-1 SD 6.0 (5.4, 6.7) -0.06 (-0.50, 0.37)
-0.5 SD 6.0 (5.4, 6.6) -0.11 (-0.31, 0.10)
0 6.1 (5.5, 6.7) Reference 
+0.5 SD 5.7 (4.6, 6.8) 0.31 (-0.01, 0.63) 
+1 SD 6.8 (6.1, 7.5) 0.78 (-0.04, 1.6) 
+1.5 SD 7.3 (6.2, 8.5) 1.3 (-0.11, 2.8) 
+2 SD 7.5 (6.1, 9.0) 1.9 (-0.22, 4.0) 
+2.5 SD 8.6 (6.0, 11) 2.5 (-0.37, 5.4) 
+3 SD 9.1 (5.8, 12) 3.0 (-0.54, 6.6) 
111 
Appendix F Sampling fractions for Specific Aim #2 
Appendix Table 11 Sample selection by prepregnancy BMI category 
Sample selection 
Prepregnancy BMI category 
Underweight Normal weight Overweight Grade 1 obese Grade 2 obese Grade 3 obese 
Total eligible, n 2,016 39,014 22,757 10,067 4,389 2,569 
Randomly selected into subcohort 1,411 1,411 1,411 1,411 1,411 1,411 
Retained as part of subcohort 1,101 907 968 1,043 1,024 970 
Retain those with serial weight 
measurements 
1,042 903 946 1,022 992 934 
Retain those with measured 
antenatal weight at 16-19 weeks 
808 821 789 841 816 753 
Retain those with complete data 807 819 789 838 814 752 
Retain those with z-scores from -4 
to +4 
800 811 787 828 806 742 
Sampling fraction 0.40 0.021 0.035 0.082 0.18 0.29 
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Appendix G Maternal characteristics by prepregnancy BMI category and cohort 
Appendix Table 12 Maternal characteristics for Specific Aim #2, Underweight and Normal weight 
Maternal characteristic 
Underweight Normal weight 
Eligible 
cohort 
(n=2,761) 
Randomly 
selected into 
subcohort with 
SMM data 
(n=1,101) 
Subcohort used in 
final sample 
(n=807) 
Eligible cohort 
(n=35,125) 
Randomly 
selected into 
subcohort with 
SMM data 
(n=907) 
Subcohort 
used in final 
sample 
(n=819) 
Percent of cohort 
Age >30 years 35 36 39 51 51 52 
Non-Hispanic White 72 73 74 79 78 79 
College graduate 39 40 43 54 54 55 
Nulliparous 53 52 53 49 49 48 
Preterm birth 13 12 10 9.2 8.5 8.3 
Preexisting 
hypertension/ diabetes 
1.1 1.2 1.0 1.7 1.1 1.2 
Married 50 50 55 66 66 68 
Private insurance 48 48 50 58 54 55 
Smoked during 
pregnancy 
23 25 21 13 11 11 
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Appendix Table 13 Maternal characteristics for Specific Aim #2, Overweight and Grade 1 Obese 
Maternal characteristic 
Overweight Grade 1 obese 
Eligible 
cohort 
(n=14,300) 
Randomly 
selected into 
subcohort with 
SMM data 
(n=968) 
Subcohort used in 
final sample 
(n=789) 
Eligible cohort 
(n=6,639) 
Randomly 
selected into 
subcohort with 
SMM data 
(n=1,043) 
Subcohort 
used in final 
sample 
(n=838) 
Percent of cohort 
Age >30 years 50 50 51 48 48 51 
Non-Hispanic White 75 78 80 72 74 77 
College graduate 46 46 50 38 38 41 
Nulliparous 44 42 42 42 40 40 
Preterm birth 10 11 10 12 12 11 
Preexisting 
hypertension/ diabetes 
4.3 5.7 5.8 9.0 9.8 10 
Married 61 62 65 57 57 61 
Private insurance 53 57 59 50 52 55 
Smoked during 
pregnancy 
14 15 13 15 16 15 
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Appendix Table 14 Maternal characteristics for Specific Aim #2, Grades 2 and 3 obese 
Maternal characteristic 
Grade 2 obese Grade 3 obese 
Eligible 
cohort 
(n=2,990) 
Randomly 
selected into 
subcohort with 
SMM data 
(n=1,024) 
Subcohort used in 
final sample 
(n=814) 
Eligible cohort 
(n=1,804) 
Randomly 
selected into 
subcohort with 
SMM data 
(n=970) 
Subcohort 
used in final 
sample 
(n=752) 
Percent of cohort 
Age >30 years 47 48 49 49 48 49 
Non-Hispanic White 71 72 74 66 67 68 
College graduate 35 35 38 29 28 30 
Nulliparous 40 41 42 39 39 39 
Preterm birth 12 11 11 15 12 11 
Preexisting 
hypertension/ diabetes 
14 14 14 21 21 20 
Married 55 56 59 53 54 55 
Private insurance 47 47 49 48 50 51 
Smoked during 
pregnancy 
16 17 16 15 16 15 
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Appendix H Severe maternal morbidity indicators by weight gain z-score category at 16-19 
weeks gestation 
Appendix Table 15 Severe maternal morbidity indicator by z-score category (N=4,774) 
Severe maternal morbidity 
indicator 
Gestational 
weight gain <-1 
SD 
Gestational weight 
gain -1 to +1 SD 
Gestational 
weight gain >+1 
SD 
Cases 
(n) 
% Cases (n) % Cases 
(n) 
% 
Overall 9 73 14 
Intensive care unit admission 0 0 28 38 4 29 
Prolonged postpartum length of 
stay 
0 0 21 29 5 36 
Acute myocardial infarction 0 0 0 0 0 0 
Acute renal failure 0 0 5 6.9 0 0 
Adult respiratory distress 
syndrome 
0 0 5 6.9 1 7.1 
Amniotic fluid embolism 0 0 1 1.4 0 0 
Aneurysm 0 0 0 0 0 0 
Cardiac arrest/ ventricular 
fibrillation 
0 0 2 2.7 0 0 
Disseminated intravascular 
coagulation 
0 0 8 11 0 0 
Eclampsia 1 11 6 8.2 1 7.1 
Heart failure during procedure or 
surgery 
1 11 15 21 5 36 
Puerperal cerebrovascular 
disorders 
0 0 5 6.9 0 0 
Pulmonary edema 0 0 0 0 0 0 
Severe anesthesia complications 1 11 3 4.1 0 0 
Sepsis 0 0 1 1.4 0 0 
Shock 0 0 4 5.5 0 0 
Sickle cell anemia with crisis 0 0 0 0 0 0 
Thrombotic embolism 1 11 2 2.7 0 0 
Blood transfusion 5 56 21 29 1 7.1 
Conversion of cardiac rhythm 0 0 0 0 0 0 
Hysterectomy 0 0 3 4.1 1 7.1 
Temporary tracheostomy 0 0 0 0 0 0 
Ventilation 0 0 1 1.4 0 0 
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Appendix I Comparison of samples for Specific Aims #1, #2, ASTRID, and MOMI cohorts 
Appendix Table 16 Maternal characteristics by cohort 
Characteristic 
Frequency of sample (%) 
MOMI 
(n=180,965) 
ASTRID
(n=97,793) 
Specific Aim #1 
(n=84,241) 
Specific Aim #2 
(n=4,774)* 
Prepreg body mass index 
   Underweight 4,331 (4.3) 8,918 (9.2) 4,096 (4.8) 800 (2.5) 
   Normal weight 52,996 (53) 17,814 (18) 43,709 (52) 811 (48) 
   Overweight 23,016 (23) 15,705 (16) 20,099 (24) 787 (28) 
   Obese 20,196 (20) 55,045 (56) 16,337 (19) 2,376 (21) 
Maternal age 
   <20 years 7,276 (6.9) 5,851 (6.0) 5,930 (7.0) 280 (6.2) 
20-30 years 47,749 (45) 45,942 (47) 38,086 (45) 2,177 (43) 
>30 years 50, 075 (48) 46,000 (47) 40,225 (48) 2,317 (51) 
Maternal race/ ethnicity 
   Non-Hispanic White 138,242 (77) 72,832 (75) 63,062 (75) 3,602 (78) 
   Non-Hispanic Black 22,419 (19) 21,503 (22) 16,540 (20) 971 (17) 
   Other (including Hispanic) 8,344 (4.6) 3,458 (3.5) 4,639 (5.5) 201 (4.9) 
Parity 
   No births 81,594 (45) 41,928 (43) 38,598 (46) 2,103 (45) 
   Previous birth 99,358 (55) 55,865 (57) 45,643 (54) 2,671 (55) 
Marital status 
   Unmarried 38,527 (37) 38,407 (39) 33,450 (40) 1,898 (35) 
   Married 66,540 (63) 59,386 (61) 50,791 (60) 2,921 (65) 
Maternal education 
   Less than high school 8,684 (8.3) 7,538 (7.7) 7,244 (8.6) 1,438(6.9) 
   High school some 
   college 
46,786 (45) 51,670 (53) 37,908 (45)  1,283 (43) 
   College graduate 49,258 (47) 38,415 (39) 38,750 (46) 2,053 (50) 
Pre hypertension or diabetes 
   Yes 9,903 (5.5) 6,106 (6.3) 3,743 (4.4) 410 (5.0) 
   No 171,062 (95) 91,399 (94) 80,498 (96) 4,364 (95) 
Smoking during pregnancy 
   Yes 15,991 (15) 13,630 (14) 12,323 (15) 715 (13) 
   No 89,010 (85) 82,847 (86) 40,630 (85) 4,059 (87) 
Insurance 
   Private 104,115 (58) 59,355 (61) 43,611 (52) 2,549 (56) 
   Public/ Other 76,566 (42) 38,428 (39) 40,630 (48) 2,225 (44) 
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Appendix Table 17 Appendix A Severe maternal morbidity indicators by gestational weight gain z-score category (N=84,241) 
Severe maternal morbidity indicator 
Gestational weight 
gain <-2 SD 
Gestational weight 
gain -2 to <+1 SD 
Gestational weight 
gain +1 to <+2 SD 
Gestational weight 
gain ≥+2 SD 
Cases (n) % Cases (n) % Cases (n) % Cases (n) % 
Intensive care unit admission 27 33 361 29 71 32 13 28 
Prolonged postpartum length of stay 21 25 307 25 60 27 16 32 
Acute myocardial infarction 0 0 1 0.08 0 0 0 0 
Acute renal failure 5 6.3 60 4.9 13 5.8 1 2.0 
Adult respiratory distress syndrome 4 5.5 65 5.3 16 7.3 1 2.0 
Amniotic fluid embolism 1 1.2 4 0.39 1 0.43 0 0 
Aneurysm 0 0 1 0.08 1 0.43 0 0 
Cardiac arrest/ ventricular fibrillation 1 1.2 5 0.46 2 1.2 0 0 
Disseminated intravascular coagulation 7 8.6 81 6.6 9 4.4 1 2.0 
Eclampsia 1 1.9 43 3.5 18 8.4 1 2.0 
Heart failure during procedure or surgery 15 19 340 27 59 26 15 31 
Puerperal cerebrovascular disorders 1 1.2 18 1.5 6 3.1 1 2.4 
Pulmonary edema 1 1.2 26 2.1 7 3.3 3 6.5 
Severe anesthesia complications 3 3.7 19 1.6 1 0.43 1 2.0 
Sepsis 2 2.4 33 2.7 3 1.6 1 2.0 
Shock 3 3.6 47 3.8 4 2.2 1 2.0 
Sickle cell anemia with crisis 1 1.2 7 0.59 0 0 0 0 
Thrombotic embolism 0 0 13 1.1 3 1.4 0 0 
Blood transfusion 30 36 367 30 59 26 12 25 
Conversion of cardiac rhythm 0 0 1 0.08 0 0 0 0 
Hysterectomy 4 5.4 75 6.1 12 5.5 0 0 
Temporary tracheostomy 0 0 1 0.08 1 0.43 0 0 
Ventilation 3 3.5 30 2.5 8 3.6 1 2.0 
118 
Appendix Table 18 Appendix A Severe maternal morbidity indicators by gestational age at 
delivery (N=84,241) 
Severe maternal morbidity 
indicator 
n(% of cases)* 
Term delivery (≥37 weeks) 
998 (54) 
Preterm delivery (<37 weeks) 
599 (36) 
ICU admission 250 (25) 224 (37) 
Prolonged postpartum length 
of stay 
207 (21) 197 (33) 
Acute myocardial infarction 0 1 (0.17) 
Acute renal failure 26 (2.6) 55 (9.2) 
Adult respiratory distress 
syndrome 
30 (3.0) 59 (9.8) 
Amniotic fluid embolism 5 (0.50) 2 (0.33) 
Aneurysm 1 (0.10) 1 (0.17) 
Cardiac arrest/ ventricular 
fibrillation 
6 (0.60) 3 (0.50) 
Disseminated intravascular 
coagulation 
58 (5.8) 42 (7.0) 
Eclampsia 34 (3.4) 33 (5.5) 
Heart failure during 
procedure or surgery 
317 (32) 114 (19) 
Puerperal cerebrovascular 
disorders 
20 (2.0) 8 (1.3) 
Pulmonary edema 13 (1.3) 26 (4.3) 
Severe anesthesia 
complications 
21 (2.1) 4 (0.67) 
Sepsis 10 (1.0) 31 (5.2) 
Shock 30 (3.0) 27 (4.5) 
Sickle cell anemia with crisis 2 (0.20) 8 (1.3) 
Thrombotic embolism 10 (1.0) 7 (1.2) 
Blood transfusion 303 (30) 166 (28) 
Conversion of cardiac rhythm 1 (0.10) 0 
Hysterectomy 46 (4.6) 47 (7.8) 
Temporary tracheostomy 0 2 (0.33) 
Ventilation 19 (9) 23 (3.8) 
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Appendix J Sensitivity analyses, Specific Aim #1 
Appendix Table 19 Estimated number of excess cases of severe maternal morbidity by outcome definition used. Magee-Womens Hospital (N=84,241)
Gestational weight 
gain  
z-score
Adjusted risk difference per 100 delivery hospitalizations (95% confidence interval) 
Primary definition 
(PD) 
PD less ICU 
admission 
PD less extended 
postpartum 
length of stay 
PD less blood 
transfusion 
Complete case 
analysis 
(n=57,922) 
-3 SD 0.30 (-0.07, 0.67) 0.23 (-0.11, 0.57) 0.25 (-0.10, 0.59) 0.22 (-0.10, 0.55) 0.25 (-0.11, 0.62) 
-2.5 SD 0.22 (-0.07, 0.51) 0.17 (-0.10, 0.43) 0.18 (-0.09, 0.45) 0.16 (-0.09 (0.41) 0.18 (-0.11, 0.47) 
-2 SD 0.14 (-0.07, 0.35) 0.10 (-0.10, 0.30) 0.12 (-0.08, 0.32) 0.09 (-0.09, 0.28) 0.11 (-0.10, 0.32) 
-1.5 SD 0.06 (-0.08, 0.21) 0.04 (-0.09, 0.17) 0.06 (-0.08, 0.19) 0.03 (-0.09, 0.16) 0.04 (-0.10, 0.18) 
-1 SD -0.01 (-0.10, 0.08) -0.02 (-0.10, 0.06) 0.001 (-0.08, 0.08) -0.03 (-0.10, 0.05) -0.02 (-0.11, 0.06)
-0.5 SD -0.04 (-0.08, -0.002) -0.04 (-0.08, -0.004) -0.03 (-0.07, 0.01) -0.05 (-0.08, -0.01) -0.05 (-0.09, -0.01)
0 Reference Reference Reference Reference Reference 
+0.5 SD 0.14 (0.08, 0.21) 0.13 (0.07, 0.19) 0.10 (0.04, 0.17) 0.14 (0.09, 0.20) 0.15 (0.09, 0.21) 
+1 SD 0.38 (0.20, 0.56) 0.34 (0.18, 0.51) 0.27 (0.10, 0.44) 0.38 (0.23, 0.53) 0.39 (0.22, 0.57) 
+1.5 SD 0.67 (0.33, 1.0) 0.61 (0.29, 0.92) 0.48 (0.16, 0.79) 0.68 (0.38, 0.97) 0.70 (0.37, 1.0) 
+2 SD 1.0 (0.46, 1.5) 0.88 (0.40, 1.4) 0.68 (0.21, 1.2) 1.0 (0.53, 1.5) 1.0 (0.51, 1.5) 
+2.5 SD 1.3 (0.58, 2.0) 1.2 (0.51, 1.9) 0.92 (0.26, 1.6) 1.4 (0.69, 2.0) 1.4 (0.66, 2.1) 
+3 SD 1.6 (0.68, 2.6) 1.5 (0.60, 2.4) 1.1 (0.29, 2.0) 1.7 (0.82, 2.6) 1.7 (0.78, 2.7) 
Notes: Primary definition (PD)= severe maternal morbidity as “presence of any one of the Centers for Disease Control and 
Prevention criteria, ICU admission, or extended postpartum length of stay (>3 days for vaginal deliveries and >5 days for cesarean 
deliveries). 
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Appendix Table 20 Estimated number of excess cases of severe maternal morbidity by specific indicator. Preterm deliveries Magee-Womens Hospital
(N=84,241) 
Severe maternal morbidity indicator 
Adjusted risk difference per 100 delivery hospitalizations (95% confidence interval) 
Gestational weight gain z-score category 
-2 -1 +1 +2
Intensive care unit admission 0.08 (-0.02, 0.18) 0.01 (-0.03, 0.05) 0.12 (0.02, 0.23) 0.33 (0.04 (0.63) 
Prolonged postpartum length of stay 0.02 (-0.08, 0.11) -0.02 (-0.05, 0.02) 0.14 (0.06, 0.23) 0.39 (0.12, 0.65) 
Acute myocardial infarction ‡ ‡ ‡ ‡ 
Acute renal failure 0.01 (-0.03, 0.05) 0.001 (-0.02, 0.02) 0.01 (-0.03, 0.05) 0.02 (-0.07, 0.12) 
Adult respiratory distress syndrome 0.01 (-0.03, 0.05) -0.002 (-0.02, 0.02) 0.03 (-0.01, 0.08) 0.10 (-0.03, 0.23) 
Amniotic fluid embolism ‡ ‡ ‡ ‡ 
Aneurysm ‡ ‡ ‡ ‡ 
Cardiac arrest/ ventricular 
fibrillation 
-0.0005 (-0.01, 0.01) -0.001 (-0.01, 0.005) 0.01 (-0.01, 0.02) 0.03 (-0.04, 0.09) 
Diss. intravascular coagulation 0.03 (-0.02, 0.07) 0.01 (-0.01, 0.03) -0.01 (-0.05, 0.03) -0.02 (-0.11, 0.07)
Eclampsia -0.01 (-0.06, 0.03) -0.01 (-0.03, 0.01) 0.04 (0.01, 0.08) 0.14 (0.0005, 0.27)
Heart fail during procedure/ surgery -0.08 (-0.21, 0.05) -0.05 (-0.11, 0.002) 0.15 (0.05, 0.24) 0.38 (0.09 (0.67) 
Puerperal cerebrovascular disorders -0.0006 (-0.02, 0.02) -0.003 (-0.01, 0.01) 0.02 (0.003, 0.04) 0.08 (-0.02, 0.18) 
Pulmonary edema 0.01 (-0.01, 0.02) -0.00008 (-0.01, 0.01) 0.02 (0.00005, 0.05) 0.07 (-0.02 (0.17) 
Severe anesthesia complications 0.01 (-0.02, 0.04) 0.003 (-0.01, 0.01) 0.00008 (-0.02, 0.02) 0.003 (-0.05, 0.06) 
Sepsis 0.001 (-0.04, 0.04) -0.0008 (-0.02, 0.02) 0.003 (-0.03, 0.03) 0.01 (-0.07, 0.08) 
Shock -0.01 (-0.06, 0.05) -0.003 (-0.03 (0.02) 0.003 (-0.04, 0.04) 0.01 (-0.1, 0.1) 
Sickle cell anemia with crisis 0.03 (-0.10, 0.13) 0.02 (-0.05, 0.10) -0.02 (-0.11, 0.07) -0.02 (-0.19, 0.15)
Thrombotic embolism -0.0001 (-0.02, 0.02) -0.001 (-0.01, 0.01) 0.01 (-0.01, 0.03) 0.02 (-0.04, 0.09)
Blood transfusion 0.08 (-0.04, 0.20) 0.03 (-0.02, 0.08) 0.02 (-0.07, 0.12) 0.06 (-0.17, 0.29)
Conversion of cardiac rhythm ‡ ‡ ‡ ‡ 
Hysterectomy 0.01 (-0.06, 0.07) 0.002 (-0.03, 0.03) 0.002 (-0.05, 0.05) 0.01 (-0.11, 0.12) 
Temporary tracheostomy ‡ ‡ ‡ ‡ 
Ventilation -0.01 (-0.05, 0.04) -0.01 (-0.03, 0.01) 0.02 (-0.01, 0.04) 0.04 (-0.04, 0.13) 
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Appendix Table 21 Estimated number of excess cases of severe maternal morbidity by outcome definition used. Preterm deliveries. Magee-Womens 
Hospital (N=84,241) 
Gestational 
weight gain 
z-score
Adjusted risk difference per 100 delivery hospitalizations (95% confidence interval) 
Primary definition (PD) 
PD less ICU 
admission 
PD less extended 
postpartum 
length of stay 
PD less blood 
transfusion 
Complete case 
analysis 
(n=57,922) 
-3 SD 0.44 (-1.4, 2.2) 0.23 (-1.4, 1.9) 0.16 (-1.6, 1.9) 0.5 (-1.1, 2.2) 1.1 (-0.94, 3.2) 
-2.5 SD 0.31 (-1.1, 1.7) 0.15 (-1.2, 1.5) 0.10 (-1.3, 1.5) 0.36 (-0.98, 1.7) 0.86 (-0.76, 2.5) 
-2 SD -0.18 (-0.90, 1.3) 0.10 (-0.93, 1.1) 0.04 (-1.0, 1.1) 0.21 (-0.79, 1.2) 0.60 (-0.59, 1.8) 
-1.5 SD 0.05 (-0.69, 0.79) -0.01 (-0.70, 0.68) -0.02 (-0.74, 0.70) 0.07 (-0.61, 0.76) 0.35 (-0.45, 1.2) 
-1 SD -0.06 (-0.50, 0.37) -0.08 (-0.49, 0.33) -0.07 (-0.50, 0.35) -0.05 (-0.45, 0.35) 0.12 (-0.35, 0.58) 
-0.5 SD -0.11 (-0.31, 0.10) -0.10 (-0.29, 0.10) -0.08 (-0.28, 0.11) -0.11 (-0.29, 0.08) -0.03 (-0.24, 0.19)
0 (Mean) Reference Reference Reference Reference Reference 
+0.5 SD 0.31 (-0.01, 0.63) 0.25 (-0.06, 0.56) 0.20 (-0.10, 0.51) 0.32 (0.03, 0.61) 0.25 (-0.08, 0.58) 
+1 SD 0.78 (-0.04, 1.6) 0.62 (-0.16, 1.4) 0.50 (-0.27, 1.3) 0.81 (0.06, 1.5) 0.67 (-0.18, 1.5) 
+1.5 SD 1.3 (-0.11, 2.8) 1.1 (-0.31, 2.4) 0.85 (-0.50, 2.2) 1.4 (0.05, 2.7) 1.2 (-0.32, 2.7) 
+2 SD 1.9 (-0.22, 4.0) 1.5 (-0.50, 3.5) 1.2 (-0.74, 3.1) 2.0 (0.01, 4.0) 1.7 (-0.51, 3.9) 
+2.5 SD 2.5 (-0.37, 5.4) 2.0 (-0.72, 4.7) 1.6 (-1.0, 4.1) 2.6 (-0.09, 5.4) 2.2 (-0.76, 5.2) 
+3 SD 3.0 (-0.54, 6.6) 2.4 (-0.95, 5.7) 1.9 (-1.3, 5.0) 3.2 (-0.20, 6.7) 2.7 (-1.0, 6.4) 
Notes: Primary definition (PD)= severe maternal morbidity as “presence of any one of the Centers for Disease Control and 
Prevention criteria, ICU admission, or extended postpartum length of stay (>3 days for vaginal deliveries and >5 days for 
cesarean deliveries). 
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Appendix Table 22 Estimated number of excess cases of severe maternal morbidity by outcome definition used. Term deliveries. Magee-Womens 
Hospital (N=84,241) 
Gestational 
weight gain 
z-score
Adjusted risk difference per 100 delivery hospitalizations (95% confidence interval) 
Primary definition 
(PD) 
PD less ICU 
admission 
PD less extended 
postpartum 
length of stay 
PD less blood 
transfusion 
Complete case 
analysis 
(n=57,922) 
-3 SD 0.01 (-0.35, 0.36) -0.01 (-0.35, 0.33) 0.03 (-0.31, 0.37) -0.06 (-0.37, 0.24) 0.01 (-0.36, 0.38) 
-2.5 SD -0.01 (-0.29, 0.28) -0.02 (-0.29, 0.25) 0.01 (-0.25, 0.28) -0.06 (-0.31, 0.18) -0.01 (-0.30, 0.28)
-2 SD -0.02 (-0.24, 0.20) -0.03 (-0.24, 0.18) 0.001 (-0.20, 0.20) -0.06 (-0.25, 0.12) -0.03 (-0.25, 0.19)
-1.5 SD -0.03 (-0.18, 0.12) -0.04 (-0.18, 0.10) -0.01 (-0.15, 0.13) -0.06 (-0.20, 0.07) -0.04 (-0.20, 0.11)
-1 SD -0.04 (-0.13, 0.04) -0.05 (-0.13, 0.04) -0.03 (-0.11, 0.06) -0.06 (-0.14, 0.01) -0.06 (-0.15, 0.03)
-0.5 SD -0.04 (-0.08, 0.00001) -0.04 (-0.08, -0.003) -0.03 (-0.06, 0.01) -0.05 (-0.08, -0.01) -0.05 (-0.09, -0.01)
0 (Mean) Reference Reference Reference Reference Reference 
+0.5 SD 0.09 (0.03, 0.15) 0.09 (0.03, 0.14) 0.06 (0.004, 0.12) 0.09 (0.04, 0.15) 0.12 (0.06, 0.18) 
+1 SD 0.22 (0.05, 0.38) 0.21 (0.06, 0.36) 0.16 (0.005, 0.31) 0.23 (0.09, 0.37) 0.30 (0.13, 0.46) 
+1.5 SD 0.37 (0.08, 0.66) 0.37 (0.09, 0.64) 0.27 (-0.004, 0.54) 0.39 (0.13, 0.66) 0.51 (0.20, 0.83) 
+2 SD 0.53 (0.09, 0.96) 0.52 (0.11, 0.93) 0.38 (-0.02, 0.78) 0.57 (0.17, 0.97) 0.75 (0.26, 1.2) 
+2.5 SD 0.70 (0.09, 1.3) 0.70 (0.11, 1.3) 0.50 (-0.05, 1.0) 0.77 (0.19, 1.3) 1.0 (0.31, 1.7) 
+3 SD 0.86 (0.09, 1.6) 0.87 (0.12, 1.6) 0.61 (-0.08, 1.3) 0.96 (0.21, 1.7) 1.3 (0.35, 2.2) 
Notes: Primary definition (PD)= severe maternal morbidity as “presence of any one of the Centers for Disease Control and 
Prevention criteria, ICU admission, or extended postpartum length of stay (>3 days for vaginal deliveries and >5 days for 
cesarean deliveries). 
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Appendix Table 23 Estimated number of excess cases of severe maternal morbidity by outcome definition used. Magee-Womens Hospital (N=84,241) 
Gestational 
weight gain 
z-score
Adjusted risk difference per 100 delivery hospitalizations (95% confidence interval) 
Primary definition 
(PD) 
Underweight Normal weight Overweight Obese 
-3 SD 0.30 (-0.07, 0.67) 1.7 (-1.7, 5.1) 0.21 (-0.20, 0.62) 0.61 (-0.31, 1.5) -0.04 (-1.0, 0.94
-2.5 SD 0.22 (-0.07, 0.51) 1.2 (-1.1, 3.6) 0.15 (-0.17, 0.47) 0.46 (-0.25, 1.2) -0.06 (-0.85, 0.73)
-2 SD 0.14 (-0.07, 0.35) 0.85 (-0.71, 2.4) 0.09 (-0.15, 0.32) 0.32 (-0.20, 0.83) -0.08 (-0.68, 0.53)
-1.5 SD 0.06 (-0.08, 0.21) 0.52 (-0.42, 1.5) 0.03 (-0.13, 0.19) 0.18 (-0.16, 0.52) -0.09 (-0.51, 0.33)
-1 SD -0.01 (-0.10, 0.08) 0.24 (-0.23, 0.71) -0.02 (-0.12, 0.07) 0.06 (-0.13, 0.26) -0.10 (-0.35, 0.15)
-0.5 SD -0.04 (-0.08, -0.002) 0.06 (-0.13, 0.24) -0.05 (-0.09, 0.00005) -0.01 (-0.10, 0.08) -0.08 (-0.20, 0.03)
0 (Mean) Reference Reference Reference Reference Reference 
+0.5 SD 0.14 (0.08, 0.21) 0.09 (-0.19, 0.38) 0.14 (0.06, 0.22) 0.13 (-0.01, 0.26) 0.17 (-0.01, 0.36) 
+1 SD 0.38 (0.20, 0.56) 0.30 (-0.47, 1.1) 0.36 (0.15, 0.57) 0.35 (-0.01, 0.70) 0.43 (-0.05, 0.91) 
+1.5 SD 0.67 (0.33, 1.0) 0.60 (-0.87, 2.1) 0.64 (0.25, 1.0) 0.62 (-0.03, 1.3) 0.73 (-0.14, 1.6) 
+2 SD 1.0 (0.46, 1.5) 0.90 (-1.4, 3.2) 0.93 (0.33, 1.5) 0.91 (-0.09, 1.9) 1.0 (-0.26, 2.3) 
+2.5 SD 1.3 (0.58, 2.0) 1.3 (-2.0, 4.5) 1.3 (0.40, 2.1) 1.2 (-0.18, 2.6) 1.4 (-0.42, 3.2) 
+3 SD 1.6 (0.68, 2.6) 1.6 (-2.7, 5.8) 1.6 (0.44, 2.7) 1.5 (-0.30, 3.3) 1.7 (-0.58, 4.0) 
Notes: Primary definition (PD)= severe maternal morbidity as “presence of any one of the Centers for Disease Control and 
Prevention criteria, ICU admission, or extended postpartum length of stay (>3 days for vaginal deliveries and >5 days for 
cesarean deliveries). 
Ref: Reference category 
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Appendix Table 24 Adjusted risk differences by select, specific indicators of severe maternal morbidity by total gestational weight gain z-score
(N=84,241) 
Selected indicator of severe 
maternal morbidity 
Adjusted risk difference per 100 delivery hospitalizations (95% confidence interval) 
Gestational weight gain z-score 
-2 SD -1 SD +1 SD +2 SD
Primary definition 0.14 (-0.07, 0.35) -0.01 (-0.10, 0.08) 0.38 (0.20, 0.56) 1.0 (0.46, 1.5) 
Intensive care unit admission 0.08 (-0.02, 0.18) 0.01 (-0.03, 0.05) 0.12 (0.02, 0.23) 0.33 (0.04, 0.63) 
Prolonged postpartum length 
of stay 
0.02 (-0.08, 0.11) -0.02 (-0.05, 0.02) 0.14 (0.06, 0.23) 0.39 (0.12, 0.65) 
Acute renal failure 0.01 (-0.03, 0.05) 0.001 (-0.02, 0.02) 0.01 (-0.03, 0.05) 0.02 (-0.07, 0.12) 
Adult respiratory distress 
syndrome 
0.01 (-0.03, 0.05) -0.002 (-0.02, 0.02) 0.03 (-0.01, 0.01) 0.01 (-0.03, 0.23) 
Disseminated intravascular 
coagulation 
0.03 (-0.02, 0.07) 0.01 (-0.01, 0.03) -0.01 (-0.05, 0.03) -0.02 (-0.11, 0.07)
Eclampsia -0.01 (-0.06, 0.03) -0.01 (-0.03, 0.01) 0.04 (0.01, 0.08) 0.13 (0.0005, 0.27) 
Heart failure during 
procedure or surgery 
-0.08 (-0.21, 0.05) -0.05 (-0.11, 0.002) 0.15 (0.05, 0.24) 0.38 (0.09 (0.67) 
Puerperal cerebrovascular 
disorders 
-0.0006 (-0.02, 0.02) -0.003 (-0.01, 0.01) 0.02 (0.003, 0.04) 0.08 (-0.02, 0.18) 
Pulmonary edema 0.01 (-0.01, 0.02) -0.00008 (-0.01 (0.01) 0.02 (0.0005, 0.05) 0.07 (-0.02, 0.17) 
Severe anesthesia 
complications 
0.01 (-0.02, 0.04) 0.002 (-0.008, 0.01) 0.00008 (-0.02, 0.02) 0.003 (-0.05, 0.06) 
Sepsis 0.001 (-0.04, 0.04) -0.00008 (-0.02, 0.02) 0.003 (-0.03, 0.03) 0.01 (-0.07, 0.08) 
Shock -0.01 (-0.06, 0.05) -0.003 (-0.03, 0.02) 0.003 (-0.04, 0.04) 0.008 (-0.08, 0.10) 
Blood transfusion 0.08 (-0.04, 0.20) 0.03 (-0.02, 0.08) 0.02 (-0.07, 0.12) 0.06 (-0.17, 0.29) 
Ventilation -0.01 (-0.05, 0.04) -0.01 (-0.03, 0.01) 0.02 (-0.01, 0.04) 0.04 (-0.04, 0.13) 
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Appendix K Sensitivity analyses, Specific Aim #2 
Appendix Figure 9 Adjusted predicted risk of severe maternal morbidity by rate of weight gain (kg per week) 
from 16-19 weeks to delivery (N=4,714) 
Appendix Table 25 Association between gestational weight gain trajectory in the second half of 
pregnancy and risk of severe maternal morbidity at delivery hospitalization (N=4,714) 
Weight gain 
quartile 
At risk (n) Cases (n) 
Adjusted risk 
(95% CI) 
Adjusted RD 
(95% CI) 
<25% 1,183 28 2.9 (1.0, 4.7) 0.65 (-1.5, 2.8) 
25-50% 1,182 22 2.2 (1.0, 3.4) Reference 
50-75% 1,174 20 1.8 (0.76, 2.9) -0.39 (-2.0, 1.2)
>75% 1,175 25 1.6 (0.72, 2.6) -0.59 (-2.1, 0.94)
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Appendix Figure 10 Adjusted predicted risk of severe maternal morbidity by gestational weight gain z-score 
at 10-13 weeks gestation  (N=4,268) 
Appendix Table 26 Association between gestational weight gain z-score at 10-13 weeks gestation and risk 
of severe maternal morbidity at delivery hospitalization (N=4,268) 
Weight gain z-
score category 
At risk (n) Cases (n) 
Adjusted risk 
(95% CI) 
Adjusted RD 
(95% CI) 
<-1 341 5 1.1 (-0.57, 2.9) -0.88 (-2.7, 0.94)
-1 to +1 3,367 62 2.0 (1.3, 2.7) Reference 
>+1 560 10 0.74 (0.12, 1.4) -1.3 (-2.2, -0.36)
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Appendix Figure 11 Adjusted predicted risk of severe maternal morbidity by gestational 
Appendix Table 27 Association between gestational weight gain z-score at 24-28 weeks gestation and risk of 
severe maternal morbidity at delivery hospitalization (N=4,272) 
Weight gain z-
score category 
At risk (n) Cases (n) 
Adjusted risk 
(95% CI) 
Adjusted RD (95% 
CI) 
<-1 439 11 3.6 (1.1, 6.1) 1.6 (1.0, 4.2) 
-1 to +1 3,135 61 2.0 (1.4, 2.7) Reference 
>+1 698 15 1.1 (0.39, 1.7) -0.97 (-1.9, -0.04)
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Appendix Figure 12 Adjusted predicted risk of severe maternal morbidity by total gestational weight gain z-
score among women with both, total weight gain and serial weight gain measurements (N=5,741) 
Appendix Table 28 Association between total gestational weight gain z-score and risk of severe maternal 
morbidity at delivery hospitalization among women with both, early and total weight gain measurements 
(N=5,741) 
Weight gain z-
score category 
At risk (n) Cases (n) 
Adjusted risk 
(95% CI) 
Adjusted RD 
(95% CI) 
<-1 745 12 2.3 (0.66, 3.9) 0.36 (-1.4, 2.1) 
-1 to +1 4,276 83 1.9 (1.3, 2.5) Reference 
>+1 702 18 1.5 (0.41, 2.6) -0.43 (-1.7, 0.80)
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Appendix L Sensitivity analyses, Specific Aim #3 
Appendix Table 29 Risk ratio of modifiable risk factors by definition of severe maternal morbidity  (N=86,260) 
Risk factor 
Risk ratio (95% CI) 
Principal analysis 
Minus blood 
transfusion 
Minus 
 ICU admission 
Minus prolonged 
postpartum length of 
stay 
1. Prepregnancy BMI≥25kg/m2 1.1 (1.01, 1.3) 1.1 (0.96, 1.2) 1.1 (0.99, 1.2) 1.1 (1.0, 1.3) 
2. ≥35 years of age at delivery 1.5 (1.3, 1.6) 1.5 (1.3, 1.7) 1.5 (1.3, 1.6) 1.4 (1.2, 1.6) 
3. No college degree 1.2 (1.1, 1.4) 1.2 (1.1, 1.4) 1.2 (1.0, 1.4) 1.3 (1.1, 1.4) 
4. Unmarried 1.01 (0.89, 1.2) 0.97 (0.83, 1.1) 1.1 (0.91, 1.2) 1.0 (0.89, 1.2) 
5. Preexisting hypertension 2.4 (2.0, 2.8) 2.5 (2.1, 3.0) 2.3 (1.9, 2.7) 2.1 (1.8, 2.5) 
6. Preexisting diabetes 2.0 (1.5, 2.5) 2.1 (1.6, 2.6) 2.0 (1.5, 2.5) 1.9 (1.4, 2.4) 
7. Smoking during pregnancy 0.92 (0.79, 1.0) 0.97 (0.82, 1.1) 0.89 (0.76, 1.0) 0.89 (0.75, 1.0) 
8. Gestational weight gain >1 SD 1.3 (1.1, 1.5) 1.4 (1.2, 1.6) 1.3 (1.1, 1.6) 1.3 (1.1, 1.5) 
9. All above risk factors 1.6 (1.1, 2.1) 1.4 (1.1, 1.7) 1.3 (1.1, 1.6) 1.4 (1.1, 1.7) 
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Appendix Table 30 Population attributable fraction of modifiable risk factors by definition of severe maternal morbidity (N=86,260) 
Risk factor 
Population attributable fraction (95% CI) 
Principal analysis 
Minus blood 
transfusion 
Minus ICU 
admission 
Minus prolonged 
postpartum length of 
stay 
1. Prepregnancy BMI≥25kg/m2 6.0 (0.83, 11) 3.8 (-1.8, 9.2) 5.1 (-0.39, 10) 6.2 (0.64, 11) 
2. ≥35 years of age at delivery 7.1 (4.6, 9.4) 8.1 (5.3, 11) 6.8 (4.2, 9.3) 6.5 (3.9, 9.1) 
3. No college degree 13 (5.7, 19) 12 (4.6, 19) 10 (3.0, 17) 13 (5.7, 20) 
4. Unmarried 1.5 (-4.9, 7.6) -1.2 (-8.4, 5.6) 2.7 (-4.1, 9.1) 1.7 (-5.1, 8.1) 
5. Preexisting hypertension 6.3 (4.8, 7.8) 6.9 (5.1, 8.6) 5.9 (4.3, 7.5) 5.3 (3.7, 6.9) 
6. Preexisting diabetes 2.4 (1.4, 3.4) 2.7 (1.6, 3.9) 2.2 (1.2, 3.3) 2.2 (1.1, 3.3) 
7. Smoking during pregnancy -1.4 (-3.7, 0.81) -0.54 (-3.1, 2.0) -1.9 (-4.3, 0.48) -2.0 (-4.4, 0.42)
8. Gestational weight gain >1 SD 4.5 (1.9, 7.1) 5.0 (2.2, 7.7) 4.5 (1.8, 7.0) 4.1 (1.4, 6.6)
9. All above risk factors 36 (14, 53)c 26 (10, 39) 23 (7.3, 37) 26 (9.2, 39) 
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